Section II - Hormones and Gestational Disorders
Published online by Cambridge University Press: 09 November 2022
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Hormones and PregnancyBasic Science and Clinical Implications, pp. 73 - 198Publisher: Cambridge University PressPrint publication year: 2022
References
References
Bachelot, A, and Binart, N. Reproductive role of prolactin. Reproduction. 2007, 133(2):361–369.CrossRefGoogle ScholarPubMed
Bernard, V, Young, J, Chanson, P, et al. New insights in prolactin: Pathological implications. Nat Rev Endocrinol. 2015, 11(5):265–275.CrossRefGoogle ScholarPubMed
Binart, N. Prolactin. In: Melmed, S, editor. The Pituitary. 2017; 129–161. London: Elsevier.CrossRefGoogle Scholar
Bernard, V, Young, J, and Binart, N. Prolactin – A pleiotropic factor in health and disease. Nat Rev Endocrinol. 2019, 15(6):356–365.CrossRefGoogle ScholarPubMed
Horseman, ND. Physiological actions and receptors. In: Tritos, NA, Klibanski, A, editors. Prolactin disorders from basic science to clinical management. 2019; 79–94. Springer Nature Switzerland AG: Humana Press.CrossRefGoogle Scholar
Newey, PJ, Gorvin, CM, and Thakker, RV. Mutant prolactin receptor and familial hyperprolactinemia. N Engl J Med. 2014, 370(10):977–978.Google ScholarPubMed
Kobayashi, T, Usui, H, Tanaka, H, et al. Variant prolactin receptor in agalactia and hyperprolactinemia. N Engl J Med. 2018, 379(23):2230–2236.CrossRefGoogle ScholarPubMed
Molitch, ME. Endocrinology in pregnancy: Management of the pregnant patient with a prolactinoma. Eur J Endocrinol. 2015, 172(5):R205–13.CrossRefGoogle ScholarPubMed
Kaiser, UB. Hyperprolactinemia and infertility: New insights. J Clin Invest. 2012, 122(10):3467–3468.Google Scholar
Sonigo, C, Bouilly, J, Carre, N, et al. Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration. J Clin Invest. 2012, 122(10):3791–3795.Google Scholar
Demura, R, Ono, M, Demura, H, et al. Prolactin directly inhibits basal as well as gonadotropin-stimulated secretion of progesterone and 17 beta-estradiol in the human ovary. J Clin Endocrinol Metab. 1982, 54(6):1246–1250.Google Scholar
Dorrington, JH, and Gore-Langton, RE. Antigonadal action of prolactin: Further studies on the mechanism of inhibition of follicle-stimulating hormone-induced aromatase activity in rat granulosa cell cultures. Endocrinology. 1982, 110(5):1701–1707.CrossRefGoogle ScholarPubMed
McNatty, KP. Relationship between plasma prolactin and the endocrine microenvironment of the developing human antral follicle. Fertil Steril. 1979, 32(4):433–438.CrossRefGoogle ScholarPubMed
Seppala, M, Ranta, T, and Hirvonen, E. Hyperprolactinaemia and luteal insufficiency. Lancet. 1976, 1(7953):229–230.CrossRefGoogle ScholarPubMed
Maiter, D. Prolactinoma and pregnancy: From the wish of conception to lactation. Ann Endocrinol (Paris). 2016, 77(2):128–134.CrossRefGoogle ScholarPubMed
Chanson, P, and Maiter, D. Prolactinoma. In: Melmed, S, editor. The Pituitary. 4th ed. 2017; 467–514. London: Elsevier.Google Scholar
Chanson, P, and Maiter, D. The epidemiology, diagnosis and treatment of prolactinomas: The old and the new. Best Pract Res Clin Endocrinol Metab. 2019:101290.Google Scholar
Souter, I, Baltagi, LM, Toth, TL, et al. Prevalence of hyperprolactinemia and abnormal magnetic resonance imaging findings in a population with infertility. Acta Obstet Gynecol Scand. 2010, 94(3):1159–1162.Google Scholar
Maiter, D. Prolactinomas in men. In: Tritos, NA, Klibanski, A, editors. Prolactin Disorders from Basic Science to Clinical Management. 2019; 189–204. Springer Nature Switzerland AG: Humana Press.Google Scholar
Ambulkar, SS, Darves-Bornoz, AL, Fantus, RJ, et al. Prevalence of hyperprolactinemia and clinically apparent prolactinomas in men undergoing fertility evaluation. Urology. 2021.CrossRefGoogle Scholar
Ben-Jonathan, N, and Hnasko, R. Dopamine as a prolactin (PRL) inhibitor. Endocr Rev. 2001, 22(6):724–763.CrossRefGoogle ScholarPubMed
Schuff, KG, Hentges, ST, Kelly, MA, et al. Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms. J Clin Invest. 2002, 110(7):973–981.Google Scholar
Freeman, ME, Kanyicska, B, Lerant, A, et al. Prolactin: Structure, function, and regulation of secretion. Physiol Rev. 2000;80(4):1523–1631.CrossRefGoogle ScholarPubMed
Boockfor, FR, Hoeffler, JP, and Frawley, LS. Estradiol induces a shift in cultured cells that release prolactin or growth hormone. Am J Physiol. 1986, 250(1 Pt 1):E103–105.Google ScholarPubMed
Ben-Jonathan, N, LaPensee, CR, and LaPensee, EW. What can we learn from rodents about prolactin in humans? Endocr Rev. 2008, 29(1):1–41.CrossRefGoogle ScholarPubMed
Dinc, H, Esen, F, Demirci, A, et al. Pituitary dimensions and volume measurements in pregnancy and post partum. MR assessment. Acta Radiol. 1998, 39(1):64–69.Google ScholarPubMed
Gonzalez, JG, Elizondo, G, Saldivar, D, et al. Pituitary gland growth during normal pregnancy: An in vivo study using magnetic resonance imaging. Am J Med. 1988, 85(2):217–220.CrossRefGoogle Scholar
Knuth, UA, and Friesen, HG. Prolactin and pregnancy. In: Martini, L, James, VHT, editors. Current Topics in Experimental Endocrinology. 1983. 69–96. 4: Elsevier.Google Scholar
Biswas, S. Prolactin in amniotic fluid: Its correlation with maternal plasma prolactin. Clin Chim Acta. 1976, 73(2):363–367.Google Scholar
Rigg, LA, Lein, A, and Yen, SS. Pattern of increase in circulating prolactin levels during human gestation. Am J Obstet Gynecol. 1977, 129(4):454–456.Google Scholar
Grattan, DR, and Kokay, IC. Prolactin: A pleiotropic neuroendocrine hormone. J Neuroendocrinol. 2008, 20(6):752–763.CrossRefGoogle ScholarPubMed
Recent advances in medically assisted conception. Report of a WHO Scientific Group. 1992, 820:1-. Geneva: WHO; 1992.Google Scholar
Soto-Pedre, E, Newey, PJ, Bevan, JS, et al. The epidemiology of hyperprolactinaemia over 20 years in the Tayside region of Scotland: The Prolactin Epidemiology, Audit and Research Study (PROLEARS). Clin Endocrinol. 2017, 86(1):60–67.CrossRefGoogle ScholarPubMed
Huang, KE, Bonfiglio, TA, and Muechler, EK. Transient hyperprolactinemia in infertile women with luteal phase deficiency. Obstet Gynecol. 1991, 78(4):651–655.Google ScholarPubMed
Molitch, ME, and Reichlin, S. Hyperprolactinemic disorders. Dis Mon. 1982, 28(9):1–58.CrossRefGoogle ScholarPubMed
Touraine, P, Plu-Bureau, G, Beji, C, et al. Long-term follow-up of 246 hyperprolactinemic patients. Acta Obstet Gynecol Scand. 2001, 80(2):162–168.Google Scholar
Lee, DY, Oh, YK, Yoon, BK, et al. Prevalence of hyperprolactinemia in adolescents and young women with menstruation-related problems. Am J Obstet Gynecol. 2012, 206(3):213 e1–5.CrossRefGoogle Scholar
Binart, N, Young, J, and Chanson, P. Prolactin assays and regulation of secretion: animal and human data. In: Tritos, NA, Klibanski, A (Eds.) Prolactin Disorders from Basic Science to Clinical Management. Contemporary Endocrinology 2019; 55–78. Springer Nature Switzerland AG: Humana Press.Google Scholar
Fahie-Wilson, M, and Smith, TP. Determination of prolactin: The macroprolactin problem. Best Pract Res Clin Endocrinol Metab. 2013, 27(5):725–742.CrossRefGoogle ScholarPubMed
Kalsi, AK, Halder, A, Jain, M, et al. Prevalence and reproductive manifestations of macroprolactinemia. Endocrine. 2019, 63(2):332–340.Google Scholar
Karavitaki, N, Thanabalasingham, G, Shore, HC, et al. Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma. Clin Endocrinol (Oxf). 2006, 65(4):524–529.Google Scholar
Dohle, GR, Colpi, GM, Hargreave, TB, et al. EAU guidelines on male infertility. Eur Urol. 2005, 48(5):703–711.Google Scholar
Patel, DP, Chandrapal, JC, and Hotaling, JM. Hormone-Based Treatments in Subfertile Males. Curr Urol Rep. 2016, 17(8):56.Google Scholar
Iglesias, P, Bernal, C, Villabona, C, et al. Prolactinomas in men: A multicentre and retrospective analysis of treatment outcome. Clin Endocrinol (Oxf). 2012, 77(2):281–287.Google Scholar
Shimon, I, and Benbassat, C. Male prolactinomas presenting with normal testosterone levels. Pituitary. 2014;17(3):246–250.CrossRefGoogle ScholarPubMed
Colao, A, Vitale, G, Cappabianca, P, et al. Outcome of cabergoline treatment in men with prolactinoma: effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis. J Clin Endocrinol Metab. 2004, 89(4):1704–1711.Google Scholar
De Rosa, M, Ciccarelli, A, Zarrilli, S, et al. The treatment with cabergoline for 24 month normalizes the quality of seminal fluid in hyperprolactinaemic males. Clin Endocrinol (Oxf). 2006, 64(3):307–313.Google Scholar
De Rosa, M, Zarrilli, S, Di Sarno, A, et al. Hyperprolactinemia in men: clinical and biochemical features and response to treatment. Endocrine. 2003, 20(1-2):75–82.Google Scholar
Pinzone, JJ, Katznelson, L, Danila, DC, et al. Primary medical therapy of micro- and macroprolactinomas in men. J Clin Endocrinol Metab. 2000, 85(9):3053–3057.Google ScholarPubMed
Molitch, M. Prolactin and pregnancy. In: Tritos, NA, Klibanski, A (Eds.), Prolactin Disorders from Basic Science to Clinical Management. Contemporary Endocrinology. 2019; 161–174. Springer Nature Switzerland AG: Humana Press.Google Scholar
Gillam, MP, Molitch, ME, Lombardi, G, et al. Advances in the treatment of prolactinomas. Endocr Rev. 2006, 27(5):485–534.CrossRefGoogle ScholarPubMed
Melmed, S, Casanueva, FF, Hoffman, AR, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011, 96(2):273–288.CrossRefGoogle ScholarPubMed
Glezer, A, and Bronstein, MD. Prolactinomas, cabergoline, and pregnancy. Endocrine. 2014, 47(1):64–69.CrossRefGoogle ScholarPubMed
Webster, J. A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation. Drug Saf. 1996, 14(4):228–238.CrossRefGoogle ScholarPubMed
Webster, J, Piscitelli, G, Polli, A, et al. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group (see comments). N Engl J Med. 1994, 331(14):904–909.CrossRefGoogle Scholar
Wang, AT, Mullan, RJ, Lane, MA, et al. Treatment of hyperprolactinemia: a systematic review and meta-analysis. Syst Rev. 2012, 1:33.Google Scholar
Ono, M, Miki, N, Amano, K, et al. Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas. J Clin Endocrinol Metab. 2010.Google Scholar
Verhelst, J, Abs, R, Maiter, D, et al. Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients. J Clin Endocrinol Metab. 1999, 84(7):2518–2522.CrossRefGoogle ScholarPubMed
Laws, ER, Jr., Fode, NC, Randall, RV, et al. Pregnancy following transsphenoidal resection of prolactin-secreting pituitary tumors. J Neurosurg. 1983, 58(5):685–688.CrossRefGoogle ScholarPubMed
Buchfelder, M, Zhao, Y, and Schlaffer, SM. Surgery for prolactinomas to date. Neuroendocrinology. 2019.Google Scholar
Zamanipoor Najafabadi, AH, Zandbergen, IM, de Vries, F, et al. Surgery as a viable alternative first-line treatment for prolactinoma patients. A systematic review and meta-analysis. J Clin Endocrinol Metab. 2020, 105(3).Google ScholarPubMed
Primeau, V, Raftopoulos, C, and Maiter, D. Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients. Eur J Endocrinol. 2012, 166(5):779–786.Google Scholar
McGarrigle, HH, Sarris, S, Little, V, et al. Induction of ovulation with clomiphene and human chorionic gonadotrophin in women with hyperprolactinaemic amenorrhoea. Br J Obstet Gynaecol. 1978, 85(9):692–697.Google Scholar
Lebbe, M, Hubinont, C, Bernard, P, et al. Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinaemic women. Clin Endocrinol (Oxf). 2010, 73(2):236–242.Google Scholar
Casanueva, FF, Molitch, ME, Schlechte, JA, et al. Guidelines of the pituitary society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf). 2006, 65(2):265–273.CrossRefGoogle ScholarPubMed
Ray, JG, Vermeulen, MJ, Bharatha, A, et al. Association between MRI exposure during pregnancy and fetal and childhood outcomes. JAMA. 2016, 316(9):952–961.CrossRefGoogle ScholarPubMed
Proenca, F, Guerreiro, C, Sa, G, et al Neuroimaging safety during pregnancy and lactation: a review. Neuroradiology. 2021.Google Scholar
Sant’ Anna, BG, Musolino, NRC, Gadelha, MR, et al. A Brazilian multicentre study evaluating pregnancies induced by cabergoline in patients harboring prolactinomas. Pituitary. 2020, 23(2):120–128.Google Scholar
Lambert, K, Rees, K, Seed, PT, et al. Macroprolactinomas and nonfunctioning pituitary adenomas and pregnancy outcomes. Obstet Gynecol. 2017, 129(1):185–194.Google Scholar
Barraud, S, Guedra, L, Delemer, B, et al. Evolution of macroprolactinomas during pregnancy: A cohort study of 85 pregnancies. Clin Endocrinol (Oxf). 2020, 92(5):421–427.CrossRefGoogle ScholarPubMed
Huang, W, and Molitch, ME. Pituitary tumors in pregnancy. Endocrinol Metab Clin North Am. 2019, 48(3):569–581.Google Scholar
Araujo, B, Belo, S, and Carvalho, D. Pregnancy and tumor outcomes in women with prolactinoma. Exp Clin Endocrinol Diabetes. 2017, 125(10):642–648.Google Scholar
Galvao, A, Goncalves, D, Moreira, M, et al. Prolactinoma and pregnancy – A series of cases including pituitary apoplexy. J Obstet Gynaecol. 2017;37(3):284–287.Google Scholar
Karaca, Z, Yarman, S, Ozbas, I, et al. How does pregnancy affect the patients with pituitary adenomas: a study on 113 pregnancies from Turkey. J Endocrinol Invest. 2018, 41(1):129–141.Google Scholar
O’Sullivan, SM, Farrant, MT, Ogilvie, CM, et al. An observational study of pregnancy and post-partum outcomes in women with prolactinoma treated with dopamine agonists. Aust N Z J Obstet Gynaecol. 2020, 60(3):405–411.Google Scholar
Schlechte, JA. Clinical practice. Prolactinoma. N Engl J Med. 2003, 349(21):2035–2041.CrossRefGoogle ScholarPubMed
Divers, WA, Jr., and Yen, SS. Prolactin-producing microadenomas in pregnancy. Obstet Gynecol. 1983, 62(4):425–429.Google Scholar
Rastogi, A, Bhansali, A, Dutta, P, et al. A comparison between intensive and conventional cabergoline treatment of newly diagnosed patients with macroprolactinoma. Clin Endocrinol (Oxf). 2013, 79(3):409–415.Google Scholar
Graillon, T, Cuny, T, Castinetti, F, et al. Surgical indications for pituitary tumors during pregnancy: a literature review. Pituitary. 2020, 23(2):189–199.Google Scholar
Grand’Maison, S, Weber, F, Bedard, MJ, et al. Pituitary apoplexy in pregnancy: A case series and literature review. Obstet Med. 2015, 8(4):177–183.Google Scholar
Kuhn, E, Weinreich, AA, Biermasz, NR, et al. Apoplexy of microprolactinomas during pregnancy. Eur J Endocrinol. 2021.Google Scholar
Molitch, ME. Prolactinoma in pregnancy. Best Pract Res Clin Endocrinol Metab. 2011, 25(6):885–896.CrossRefGoogle ScholarPubMed
Auriemma, RS, Perone, Y, Di Sarno, A, Grasso, LF, Guerra, E, Gasperi, M, et al. Results of a single-center observational 10-year survey study on recurrence of hyperprolactinemia after pregnancy and lactation. J Clin Endocrinol Metab. 2013, 98(1):372–379.Google Scholar
Domingue, ME, Devuyst, F, Alexopoulou, O, et al. Outcome of prolactinoma after pregnancy and lactation: a study on 73 patients. Clin Endocrinol (Oxf). 2014, 80(5):642–648.Google Scholar
Ikegami, H, Aono, T, Koizumi, K, et al. Relationship between the methods of treatment for prolactinomas and the puerperal lactation. Fertil Steril. 1987, 47(5):867–869.CrossRefGoogle ScholarPubMed
Bern, HA, and Nicoll, CS. The comparative endocrinology of prolactin. Recent Prog Horm Res. 1968, 24:681–720.Google ScholarPubMed
Biswas, S, and Rodeck, CH. Plasma prolactin levels during pregnancy. Br J Obstet Gynaecol. 1976, 83(9):683–687.Google Scholar
Karunakaran, S, Page, RC, and Wass, JA. The effect of the menopause on prolactin levels in patients with hyperprolactinaemia. Clin Endocrinol (Oxf). 2001, 54(3):295–300.Google Scholar
Huda, MS, Athauda, NB, Teh, MM, et al. Factors determining the remission of microprolactinomas after dopamine agonist withdrawal. Clin Endocrinol (Oxf). 2010, 72(4):507–511.CrossRefGoogle ScholarPubMed
References
Freemark, M. Placental hormones and the control of fetal growth. J Clin Endocrinol Metab. 2010, 95:2054–2057.Google Scholar
Monaghan, JM, Godber, IM, Lawson, N, et al. Longitudinal changes of insulin-like growth factors and their binding proteins troughout normal pregnancy. Ann Clin Biochem. 2004, 41:220–226.CrossRefGoogle Scholar
Asvold, BO, Eskild, A, Jenum, PA, et al. Maternal concentrations of insulin-like growth factor I and insulin-like growth factor binding protein 1 during pregnancy and birth weight of offspring. Am J Epidemiol. 2011, 174:129–135.Google Scholar
Dosouto, C, Calaf, J, Polo, A, et al. Growth hormone and reproduction: Lessons learned from animal models and clinical trials. Frontiers Endocrinol. 10.404. https://doi.org/10.3389/fendo.2019.00404.Google Scholar
Li, J, Chen, Q, Wang, J, et al. Does growth hormone supplementation improve oocyte competence and IVF outcomes in patients with poor embryonic development? A randomized controlled trial. BMC Pregnancy and Childbirth. 2020, 20:310. https://doi.org/10.1186/s12884–020-03004-9.Google Scholar
Cozzolino, M, Cecchino, GN, Trojano, DG, et al. Growth hormone cotreatment for poor responders undergoing in vitro fertilization cycles: A systematic review and meta-analysis. Fertil Steril. 2020, 114:97–107.CrossRefGoogle ScholarPubMed
The ESHRE Guideline Group on Ovarian Stimulation, Bosch, M, et al. ESHRE guideline: Ovarian stimulation for IVF/ICSI. Human Reproduction Open 2020; p. 1–3. https://doi.org/10.1093/hropen/hoaa009.Google Scholar
de Boer, JA, Schoemaker, J, and van der Veen, EA. Impaired reproductive function in women treated for growth hormone deficiency during childhood. Clin Endocrinol. 1997, 46:681–689.Google Scholar
Giampetro, A, Milardi, D, Bianchi, A, et al. The effect of treatment with growth hormone on fertility outcome in eugonadal women with growth hormone deficiency: Report of four cases and review of the literature. Fertil Steril. 2009, 91:930e7–930e11.Google Scholar
Tsilchorozidou, T, and Conway, GS. Uterus size and ovarian morphology in women with isolated growth hormone deficiency, hypogonadotrophic hypogonadism and hypopituitarism. Clin Endocrinol. 2004, 61:567–572.Google Scholar
Ipsa, E, Cruzat, VF, Kagize, JN, et al. Growth hormone and insulin-like growth factor action in reproductive tissues. Frontiers Endocrinol. 2019, 10:777. https://doi.org/10.3389/fendo.2019.00777.Google Scholar
Vila, G, and Luger, A. Growth hormone deficiency and pregnancy: Any role for substitution? Minerva Endocrinol. 2018, 43:451–457.Google Scholar
Vila, G, Akerblad, AC, Mattsson, A, et al. Pregnancy outcomes in women with growth hormone deficiency. Fertil Steril. 2015, 104:1210–1217.CrossRefGoogle ScholarPubMed
Luger, A, Broersen, LHA, Biermasz, NR, et al. Functioning and nonfunctioning pituitary adenomas in pregnancy. An ESE clinical practice guideline. Eur J Endocrinol. 2021,185:G1–G33Google Scholar
Casanueva, FF, Barkan, AL, Buchfelder, M, et al. Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society statement. Pituitary. 2017, 20:489–498.Google Scholar
Grynberg, M, Salenave, S, Young, J, et al. Female gonadal function before and after treatment of acromegaly. J Clin Endocrinol Metab. 2010, 95:4518–4525.Google Scholar
Caron, P, Broussaud, S, Bertherat, J, et al. Acromegaly and pregnancy: A retrospective multicenter study of 59 pregnancies in 46 women. J Clin Endocrinol Metab. 2010, 95:4680–4687.Google Scholar
Katznelson, L, Laws, ER, Melmed, S, et al. Acromegaly: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2014, 99:3933–3951.CrossRefGoogle ScholarPubMed
van der Lely, AJ, Gomez, R, Heissler, JF, et al. Pregnancy in acromegaly patients treated with pegvisomant. Endocrine. 2015, 49:769–773.Google Scholar
ACOG Committee Opinion. Guidelines for diagnostic imaging during pregnancy and lactation. Obstetrics Gynecol. 1017, 130:e210–e216.Google Scholar
Chanson, P, Vialon, M, and Caron, P. An update on clinical care for pregnant women with acromegaly. Exp Rev Endocrinol Metab. 2019, 14:85–96.Google Scholar
Abucham, J, Bronstein, MD, and Dias, ML. Acromegaly and pregnancy: A contemporary review. Eur J Endocrinol. 2017, 177:R1–R12.Google Scholar
Abs, R, Verhelst, J, Maiter, D, et al. Cabergoline in the treatment of acromegaly: A study in 64 patients. J Clin Endocrinol Metab. 1998, 83:374–378.Google Scholar
Graillon, T, Cuny, T, Castinetti, F, et al. Surgical indications for pituitary tumors during pregnancy: A literature review. Pituitary. 2020, 23:189–199.Google Scholar
Alexopoulou, O, Bex, M, Kamenicky, P, et al. Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: A study in 148 patients. Pituitary. 2014, 17:81–89.Google Scholar
Ciresi, A, Amato, MC, Pivonello, R, et al. The metabolic profile in active acromegaly is gender-specific. J Clin Endocrinol Meta. 2013, 98:E51–E59.CrossRefGoogle ScholarPubMed
Vialon, M, Grunenwald, S, Mouly, C, et al. Gestational diabetes and acromegaly: Single-centre experience in 14 pregnancies. Clin Endocrinol. 2019, 91:805–809.Google Scholar
References
Hod, M, Kapur, A, Sacks, DA, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis, management, and care. Int J Gynecol Obstet. 2015, 131(S3):S173–211.Google Scholar
Catalano, PM, Tyzbir, ED, and Roman, MN. Longitudinal changes in insulin release and insulin resistance in non obese pregnant women. Am J Ob Gynecol. 1991, 165: 1667–1672.Google Scholar
Di Cianni, G, Miccoli, R, Volpe, L, et al. Intermediate metabolism in normal pregnancy and in gestational diabetes. Diabetes Metabol Res Review. 2003, 19:259–270.Google Scholar
Hernandez, TL, Friedman, JE, Van Pelt, RE, et al. Patterns of glycemia in normal pregnancy: Should the current therapeutic targets be challenged? Diabetes Care. 2011, 34(7):1660–1668.CrossRefGoogle ScholarPubMed
Butte, NF. Carbohydrate and lipid metabolism in pregnancy: Normal compared with gestational diabetes mellitus. Am J Clin Nutr. 2000, 71(5):1256S–1261S.Google Scholar
Ryan, EA, and Enns, L. Role of gestational hormones in the induction of insulin resistance. J Clin Endocrinol Metab. 1988, 67:341–347.Google Scholar
Zhou, J, Wu, NN, Yin, RL, et al. Activation of brown adipocytes by placentalgrowth factor. Biochem Biophys Res Commun. 2018, 504:470–477.Google Scholar
Powe, CE. Early pregnancy biochemical predictors of gestational diabetes mellitus. Curr Diab Rep. 2017, 17(2):12.Google Scholar
Simpson, S, Smith, L, and Bowe, J. Placental peptides regulating islet adaptation to pregnancy: Clinical potential in gestational diabetes mellitus. Curr Opin Pharmacol. 2018, 43:59–65.Google Scholar
Lorenzo-Almorós, A, et al. Predictive and diagnostic biomarkers for gestational diabetes and its associated metabolic and cardiovascular diseases. Cardiovasc Diabetol. 2019, 30;18(1):140.Google Scholar
McIntyre, HD, Chang, AM, Callaway, LK, et al. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study cooperative research group: Hormonal and metabolic factors associated with variations in insulin sensitivity in human pregnancy. Diabetes Care. 2010, 33:356–360.Google Scholar
Catalano, PM, Hoegh, M, Minium, J, et al. Adiponectin in human pregnancy: Implications for regulation of glucose and lipid metabolism. Diabetologia. 2006, 49:1677–1685.Google Scholar
Buchanan, TA. Pancreatic B cell defects in gestational diabetes: Implications for the pathogenesis and prevention of type 2 diabetes. J. Clin. Endocrinol. Metab. 2001, 86:989–993.Google Scholar
Abouzeid, M, Versace, VL, Janus, ED, et al. Socio-cultural disparities in GDM burden differ by maternal age at first delivery. PLoS ONE. 2015, 10(2):e0117085.CrossRefGoogle ScholarPubMed
Schwartz, N, Nachum, Z, and Green, MS. The prevalence of gestational diabetes mellitus recurrence – Effect of ethnicity and parity: A metaanalysis. Am J Obstet Gynecol. 2015, 213(3):310–317.CrossRefGoogle ScholarPubMed
Palomba, S, de Wilde, MA, Falbo, A, et al. Pregnancy complications in women with polycystic ovary syndrome. Hum Reprod Update. 2015, 21(5):575–592.Google Scholar
HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008, 358:1991–2002.Google Scholar
International Association of Diabetes and Pregnancy Study Groups Consensus Panel. Metzger, BE, Gabbe, SG, Persson, B, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010, 33(3):676–682.Google Scholar
McIntyre, HD, Sacks, DA, Barbour, LA, et al. Issues with the diagnosis and classification of hyperglycemia in early pregnancy. Diabetes Care. 2016, 39(1):53–54.Google Scholar
Mitanchez, D, Yzydorczyk, C, Siddeek, B, et al. The offspring of the diabetic mother – Short- and long-term implications. Best Pract Res ClinObstet Gynaecol. 2015, 29: 256–269.Google Scholar
Rosenstein, MG, Cheng, YW, Snowden, JM, et al. The risk of stillbirth and infant death stratified by gestational age in women with gestational diabetes. Am J Obstet Gynecol. 2012, 206(4):309.e1–7.Google Scholar
Mastrogiannis, DS, Spiliopoulos, M, Mulla, W, et al. Insulin resistance: The possible link between gestational diabetes mellitus and hypertensive disorders of pregnancy. Curr Diab Rep. 2009, 9(4):296–302.Google Scholar
Khan, GH, Galazis, N, Docheva, N, et al. Overlap of proteomics biomarkers between women with pre-eclampsia and PCOS: A systematic review and biomarker database integration. Hum Reprod. 2015, 30:133–148.Google Scholar
Desoye, G, and Hauguel-de, MS. The human placenta in gestational diabetes mellitus: The insulin and cytokine network. Diabetes Care. 2007, 30(S2):S120–S126.Google Scholar
Kim, C, Newton, KM, and Knopp, RH. Gestational diabetes and the incidence of type 2 diabetes: A systematic review. Diabetes Care. 2002, 25:1862–1868.CrossRefGoogle ScholarPubMed
Bellamy, L, Casas, JP, Hingorani, AD, et al. Type 2 diabetes mellitus after gestational diabetes: A systematic review and meta-analysis. Lancet. 2009, 373(9677):1773–1779.Google Scholar
Guo, J, Chen, JL, Whittemore, R, et al. Postpartum lifestyle interventions to prevent type 2 diabetes among women with history of gestational diabetes: A systematic review of randomized clinical trials. J Women’s Health. 2016, 25(1):38–49.Google Scholar
Golden, SH, Bennett, WL, Baptist-Roberts, K, et al. Antepartum glucose tolerance test results as predictors of type 2 diabetes mellitus in women with a history of gestational diabetes mellitus: A systematic review. Gend. Med. 2009, 6(S1):109–122.Google Scholar
Shah, BR, Retnakaran, R, and Booth, GL. Increased risk of cardiovascular disease in young women following gestational diabetes mellitus. Diabetes Care. 2008, 31:1668–1669.Google Scholar
Tobias, DK, Stuart, JJ, Li, S, et al. Association of history of gestational diabetes with long-term cardiovascular disease risk in a large prospective cohort of US women. JAMA Intern Med. 2017, 177(12):1735–1742.Google Scholar
Retnakaran, R, and Shah, BR. Role of type 2 diabetes in determining retinal, renal, and cardiovascular outcomes in women with previous gestational diabetes mellitus. Diabetes Care. 2017, 40:101–108.Google Scholar
Clausen, TD, et al. High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: The role of intrauterine hyperglycemia. Diabetes Care. 2008, 31:340–346.Google Scholar
Lowe, WL Jr., et al. Association of gestational diabetes with maternal disorders of glucose metabolism and childhood adiposity. JAMA. 2018, 320:1005–1016.Google Scholar
Crowther, CA, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005, 352:2477–2486.Google Scholar
Landon, MB, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009, 361:1339–1348.Google Scholar
American Diabetes Association. 13. Management of diabetes in pregnancy: sStandards of medical care in diabetes – 2020. Diabetes Care. 2020, 43(Suppl 1):S183–S192.Google Scholar
Italian National Guidelines (Linee Guida Gravidanza Fisiologica). Sistema nazionale per le linee guida dell’Istituto Superiore di Sanità. Available at: www.snlg-iss.it/cms/files/Lg.Gravidanza.pdf.Google Scholar
Martis, R, Crowther, CA, Shepherd, E, et al. Treatments for women with gestational diabetes mellitus: An overview of Cochrane systematic reviews. Cochrane Database Syst Rev. 2018, 8:CD012327.Google Scholar
Brown, J, Grzeskowiak, L, Williamson, K, et al. Insulin for the treatment of women with gestational diabetes. Cochrane Database Syst Rev. 2017, 11:CD012037.Google Scholar
Mecacci, F, Lisi, F, Vannuccini, S, et al. Different gestational diabetes phenotypes: Which insulin regimen fits better? Front. Endocrinol. 2021.Google Scholar
Rowan, JA, Hague, WM, Gao, W, et al. MiG trial investigators: Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med. 2008, 358: 2003–2015.Google Scholar
Balsells, M, Garca-Patterson, A, Sol, I, et al. Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: A systematic review and meta-analysis. BMJ. 2015, 350:h102.Google Scholar
Ijas, H., Vaarasmaki, M., Saarela, , et al. A follow-up of a randomised study of metformin and insulin in gestational diabetes mellitus: Growth and development of the children at the age of 18 months. BJOG. 2015, 122:994–1000.Google Scholar
Rowan, JA, Rush, EC, Plank, LD, et al. Metformin in gestational diabetes: The offspring follow-up (MiG TOFU): Body composition and metabolic outcomes at 7–9 years of age. BMJ Open Diabetes Res Care. 2018, 6:e000456.Google Scholar
van Weelden, W, Wekker, V, de Wit, L, et al. Long-term effects of oral antidiabetic drugs during pregnancy on offspring: A systematic review and meta-analysis of follow-up studies of RCTs. Diabetes Ther. 2018, 9:1811–1829.Google Scholar
Shepherd, E, Gomersall, JC, Tieu, J, et al. Combined diet and exercise interventions for preventing gestational diabetes mellitus. Cochrane Database Syst Rev. 2017, 11(11):CD010443.Google Scholar
Glazer, NL, Hendrickson, AF, Schellenbaum, GD, et al. Weight change and the risk of gestational diabetes in obese women. Epidemiology. 2004, 15(6):733–737.Google Scholar
Santamaria, A, Alibrandi, A, Di Benedetto, A ,et al. Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: A secondary analysis from 3 RCTs. Am J Obstet Gynecol. 2018, 219(3):300.e1–300.Google Scholar
Dodd, JM et al. Effect of metformin in addition to dietary and lifestyle advice for pregnant women who are overweight or obese: The GRoW randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2019, 7:15–24.Google Scholar
Chiswick, C, et al. Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): A randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2015, 3:778–786.Google Scholar
Zeng, XL, Zhang, YF, Tian, Q, et al. Effects of metformin on pregnancy outcomes in women with polycystic ovary syndrome: A meta-analysis. Medicine (Baltimore). 2016, 95(36):e4526.Google Scholar
References
Jones, DS, Podolsky, SH, and Greene, JA. The burden of disease and the changing task of medicine. The New England Journal of Medicine. 2012, 366:2333–2338.Google Scholar
(NCCDPHP) CsNCfCDPaHP. Chronic Diseases in America. In: (NCCDPHP) NCfCDPaHP, ed.: Center for Disease Control and Prevention, 2021.Google Scholar
Turnbaugh, PJ, Ley, RE, Mahowald, MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006, 444:1027–1031.Google Scholar
Hales, CM, Carroll, MD, Fryar, CD, et al. Prevalence of Obesity and Severe Obesity Among Adults: United States, 2017-2018. NCHS data brief 2020:1-8.Google Scholar
Barnes, AS. The epidemic of obesity and diabetes: Trends and treatments. Texas Heart Institute Journal. 2011, 38:142–144.Google Scholar
Eriksson, J, Forsén, T, Tuomilehto, J, et al. Size at birth, childhood growth and obesity in adult life. International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 2001, 25:735–740.Google Scholar
Rolland-Cachera, MF, Deheeger, M, Maillot, M, et al. Early adiposity rebound: Causes and consequences for obesity in children and adults. International Journal of Obesity. 2005, 30 Suppl (4):S11–S17.Google Scholar
Hales, CM, Fryar, CD, Carroll, MD, et al. Trends in obesity and severe obesity prevalence in US youth and adults by sex and age, 2007–2008 to 2015–2016. JAMA. 2018, 319:1723–1725.Google Scholar
Deputy, NP, Dub, B, and Sharma, AJ. Prevalence and trends in prepregnancy normal weight - 48 states, New York City, and District of Columbia, 2011–2015. MMWR Morbidity and Mortality Weekly Report. 2018, 66:1402–1407.Google Scholar
Neeland, IJ, Poirier, P, and Després, JP. Cardiovascular and metabolic heterogeneity of obesity: Clinical challenges and implications for management. Circulation. 2018, 137:1391–1406.Google Scholar
ACOG Practice Bulletin No 156: Obesity in pregnancy. Obstetrics and Gynecology. 2015, 126:e112–e126.Google Scholar
Villamor, E, and Cnattingius, S. Interpregnancy weight change and risk of adverse pregnancy outcomes: A population-based study. Lancet. 2006, 368:1164–1170.Google Scholar
Harmon, KA, Gerard, L, Jensen, DR, et al. Continuous glucose profiles in obese and normal-weight pregnant women on a controlled diet: Metabolic determinants of fetal growth. Diabetes Care. 2011, 34:2198–2204.Google Scholar
Hedman, AM, Lundholm, C, Andolf, E, et al. Longitudinal plasma inflammatory proteome profiling during pregnancy in the Born into Life study. Scientific Reports. 2020, 10:17819.Google Scholar
Catalano, PM, and Shankar, K. Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child. BMJ (Clinical Research Ed.). 2017, 356:j1.Google Scholar
Davis, NL SA, and Goodman, DA. Pregnancy-Related Deaths: Data from 14 U.S. Maternal Mortality Review Committees, 2008–2017. Centers for Disease Control and Prevention, US Department of Health and Human Services, 2019.Google Scholar
Ende, HB, Lozada, MJ, Chestnut, DH, et al. Risk factors for atonic postpartum hemorrhage: A systematic review and meta-analysis. Obstetrics and Gynecology. 2021, 137:305–323.Google Scholar
Cnattingius, S, Villamor, E, Johansson, S, et al. Maternal obesity and risk of preterm delivery. JAMA. 2013, 309:2362–2370.Google Scholar
Aune, D, Saugstad, OD, Henriksen, T, et al. Maternal body mass index and the risk of fetal death, stillbirth, and infant death: A systematic review and meta-analysis. JAMA. 2014, 311:1536–1546.Google Scholar
Best, KE, Tennant, PW, Bell, R, et al. Impact of maternal body mass index on the antenatal detection of congenital anomalies. BJOG: An International Journal of Obstetrics and Gynaecology. 2012, 119:1503–1511.Google Scholar
Pucci, A, and Batterham, RL. Endocrinology of the gut and the regulation of body weight and metabolism. In: Feingold, KR, Anawalt, B, Boyce, A, Chrousos, G, de Herder, WW, Dungan, K, et al., eds. Endotext. South Dartmouth, MA: MDText.com, Inc. 2000.Google Scholar
Barsh, GS, and Schwartz, MW. Genetic approaches to studying energy balance: Perception and integration. Nature Reviews Genetics. 2002, 3:589–600.Google Scholar
Wallace, JM, Bhattacharya, S, and Horgan, GW. Weight change across the start of three consecutive pregnancies and the risk of maternal morbidity and SGA birth at the second and third pregnancy. PLoS ONE. 2017, 12:e0179589.Google Scholar
Peaceman, AM, Clifton, RG, Phelan, S, et al. Lifestyle interventions limit gestational weight gain in women with overweight or obesity: LIFE-Moms prospective meta-analysis. Obesity. 2018, 26:1396–1404.Google Scholar
Phelan, S, Clifton, RG, Haire-Joshu, D, et al. One-year postpartum anthropometric outcomes in mothers and children in the LIFE-Moms lifestyle intervention clinical trials. International Journal of Obesity. 2005, 2020(44):57–68.Google Scholar
Knowler, WC, Barrett-Connor, E, Fowler, SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine. 2002, 346:393–403.Google Scholar
Tchang, BG, Kumar, RB, and Aronne, LJ. Pharmacologic treatment of overweight and obesity in adults. In: Feingold, KR, Anawalt, B, Boyce, A, Chrousos, G, de Herder, WW, Dungan, K. et al., eds. Endotext. South Dartmouth, MA: MDText.com, Inc. 2000.Google Scholar
Courcoulas, AP, King, WC, Belle, SH, et al. Seven-year weight trajectories and health outcomes in the Longitudinal Assessment of Bariatric Surgery (LABS) Study. JAMA Surgery. 2018, 153:427–434.Google Scholar
Benjamin, RH, Littlejohn, S, and Mitchell, LE. Bariatric surgery and birth defects: A systematic literature review. Paediatric and Perinatal Epidemiology. 2018, 32:533–544.Google Scholar
Neovius, M, Pasternak, B, Näslund, I, et al. Association of maternal gastric bypass surgery with offspring birth defects. JAMA. 2019, 322:1515–1517.Google Scholar
Elder, KA, and Wolfe, BM. Bariatric surgery: A review of procedures and outcomes. Gastroenterology. 2007, 132:2253–2271.Google Scholar
Kral, JG, Biron, S, Simard, S, et al. Large maternal weight loss from obesity surgery prevents transmission of obesity to children who were followed for 2 to 18 years. Pediatrics. 2006, 118:e1644–1649.Google Scholar
Smith, J, Cianflone, K, Biron, S, et al. Effects of maternal surgical weight loss in mothers on intergenerational transmission of obesity. The Journal of Clinical Endocrinology and Metabolism. 2009, 94:4275–4283.Google Scholar
Willmer, M, Berglind, D, Tynelius, P, et al. Children’s weight status, body esteem, and self-concept after maternal gastric bypass surgery. Surgery for Obesity and Related Eiseases: Official Journal of the American Society for Bariatric Surgery. 2015, 11:927–932.Google Scholar
Barisione, M, Carlini, F, Gradaschi, R, et al. Body weight at developmental age in siblings born to mothers before and after surgically induced weight loss. Surgery for Obesity and Related Diseases: Official Journal of the American Society for Bariatric Surgery. 2012, 8:387–391.Google Scholar
Willmer, M, Berglind, D, Sørensen, TI, et al. Surgically induced interpregnancy weight loss and prevalence of overweight and obesity in offspring. PLoS ONE. 2013, 8:e82247.Google Scholar
Guénard, F, Deshaies, Y, Cianflone, K, et al. Differential methylation in glucoregulatory genes of offspring born before vs. after maternal gastrointestinal bypass surgery. Proceedings of the National Academy of Sciences of the United States of America. 2013, 110:11439–11444.Google Scholar
Berglind, D, Müller, P, Willmer, M, et al. Differential methylation in inflammation and type 2 diabetes genes in siblings born before and after maternal bariatric surgery. Obesity. 2016, 24:250–261.Google Scholar
Svane, MS, Bojsen-Møller, KN, Martinussen, C, et al. Postprandial nutrient handling and gastrointestinal hormone secretion after Roux-en-Y gastric bypass vs sleeve gastrectomy. Gastroenterology. 2019, 156:1627–1641.e1.Google Scholar
Nohr, EA, Bech, BH, Davies, MJ, et al. Prepregnancy obesity and fetal death: A study within the Danish National Birth Cohort. Obstetrics and Gynecology. 2005, 106:250–259.Google Scholar
Ikedionwu, CA, Dongarwar, D, Yusuf, KK, et al. Pre-pregnancy maternal obesity, macrosomia, and risk of stillbirth: A population-based study. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2020, 252:1–6.Google Scholar
Marshall, NE, Guild, C, Cheng, YW, et al. Maternal superobesity and perinatal outcomes. American Journal of Obstetrics and Gynecology. 2012, 206(417):e1–6.Google Scholar
Beta, J, Khan, N, Khalil, A, et al. Maternal and neonatal complications of fetal macrosomia: Systematic review and meta-analysis. Ultrasound in Obstetrics & Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology. 2019, 54:308–318.Google Scholar
Desai, M, and Ross, MG. Fetal programming of adipose tissue: Effects of intrauterine growth restriction and maternal obesity/high-fat diet. Seminars in Reproductive Medicine. 2011, 29:237–245.CrossRefGoogle ScholarPubMed
Kislal, S, Shook, LL, and Edlow, AG. Perinatal exposure to maternal obesity: Lasting cardiometabolic impact on offspring. Prenatal Diagnosis. 2020, 40:1109–11025.Google Scholar
Heslehurst, N, Vieira, R, Akhter, Z, et al. The association between maternal body mass index and child obesity: A systematic review and meta-analysis. PLoS Medicine. 2019, 16:e1002817.Google Scholar
Brumbaugh, DE, Tearse, P, Cree-Green, M, et al. Intrahepatic fat is increased in the neonatal offspring of obese women with gestational diabetes. The Journal of Pediatrics. 2013, 162:930–936.e1.Google Scholar
Cirulli, F, Musillo, C, and Berry, A. Maternal obesity as a risk factor for brain development and mental health in the offspring. Neuroscience. 2020, 447:122–135.Google Scholar
Basu, S, Haghiac, M, Surace, P, et al. Pregravid obesity associates with increased maternal endotoxemia and metabolic inflammation. Obesity. 2011, 19:476–482.Google Scholar
Marshall, NE, Lau, B, Purnell, JQ, et al. Impact of maternal obesity and breastfeeding intention on lactation intensity and duration. Maternal & Child Nutrition. 2019, 15:e12732.Google Scholar
Kugyelka, JG, Rasmussen, KM, and Frongillo, EA. Maternal obesity is negatively associated with breastfeeding success among Hispanic but not Black women. The Journal of Nutrition. 2004, 134:1746–1753.Google Scholar
Chapman, DJ, and Pérez-Escamilla, R. Maternal perception of the onset of lactation is a valid, public health indicator of lactogenesis stage II. The Journal of Nutrition. 2000, 130:2972–2980.Google Scholar
Amir, LH, and Donath, S. A systematic review of maternal obesity and breastfeeding intention, initiation and duration. BMC Pregnancy and Childbirth. 2007, 7:9.Google Scholar
Piercy, KL, and Troiano, RP. Physical activity guidelines for Americans from the US Department of Health and Human Services. Circulation Cardiovascular Quality and Outcomes. 2018, 11:e005263.Google Scholar
Agriculture USDo SU. Dietary Guidelines for Americans, 2020–2025. In: USDoHaH, ed. Vol. 9th Edition. 2020.Google Scholar
ACOG Committee opinion no. 548: Weight gain during pregnancy. Obstetrics and Gynecology. 2013, 121:210–212.Google Scholar
Voerman, E, Santos, S, Inskip, H, et al. Association of gestational weight gain with adverse maternal and infant outcomes. JAMA. 2019, 321:1702–1715.Google Scholar
Poston, L, Bell, R, Croker, H, et al. Effect of a behavioural intervention in obese pregnant women (the UPBEAT study): A multicentre, randomised controlled trial. The Lancet Diabetes & Endocrinology. 2015, 3:767–77.Google Scholar
Luppino, FS, de Wit, LM, Bouvy, PF, et al. Overweight, obesity, and depression: A systematic review and meta-analysis of longitudinal studies. Archives of General Psychiatry. 2010, 67:220–229.Google Scholar
References
Chawanpaiboon, S, Vogel, JP, Moller, A-B, et al. Global, regional, and national estimates of levels of preterm birth in 2014: A systematic review and modelling analysis. The Lancet Global Health. 2019, 7(1):e37–e46.Google Scholar
UNICEF, WHO, World Bank Group and United Nations. United Nations Inter-agency Group for Child Mortality Estimation (UN IGME). Levels & Trends in Child Mortality: Report 2019, Estimates Developed by the United Nations Inter-Agency Group for Child Mortality Estimation. New York: 2019.Google Scholar
Blencowe, H, Cousens, S, Oestergaard, MZ, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: A systematic analysis and implications. The Lancet. 2012, 379(9832):2162–2172.Google Scholar
Goldenberg, RL, Culhane, JF, Iams, JD, et al. Epidemiology and causes of preterm birth. The Lancet. 2008, 371(9606):75–84.Google Scholar
Mactier, H, Bates, SE, Johnston, T, et al. Perinatal management of extreme preterm birth before 27 weeks of gestation: A framework for practice. Archives of Disease in Childhood: Fetal and Neonatal Edition. 2020, 105(3):232.CrossRefGoogle ScholarPubMed
Hezelgrave, N, and Shennan, A. Threatened and actual preterm labor. In: James, D, Steer, P, Weiner, C, , B G, Sc, R, (Eds.), High-Risk Pregnancy Management Options. 2. Fifth Ed, 2017; 1624–1647. Cambridge: Cambridge University Press.Google Scholar
Stock, SJ, Wotherspoon, LM, Boyd, KA, et al. Quantitative fibronectin to help decision-making in women with symptoms of preterm labour (QUIDS) part 1: Individual participant data meta-analysis and health economic analysis. BMJ Open. 2018, 8(4):e020796.Google Scholar
Barros, FC, Papageorghiou, AT, Victora, CG, et al. The distribution of clinical phenotypes of preterm birth syndrome: Implications for prevention. JAMA Pediatrics. 2015, 169(3):220–229.Google Scholar
Rood, KM, and Buhimschi, CS. Genetics, hormonal influences, and preterm birth. Seminars in Perinatology. 2017, 41(7):401–408.Google Scholar
Villar, J, Papageorghiou, AT, Knight, HE, et al. The preterm birth syndrome: A prototype phenotypic classification. Am Journal of Obstetrics and Gynecology. 2012, 206(2):119–123.Google Scholar
Cobo, T, Kacerovsky, M, and Jacobsson, B. Risk factors for spontaneous preterm delivery. International Journal of Gynecology & Obstetrics. 2020, 150(1):17–23.Google Scholar
Goodfellow, L, Care, A, and Alfirevic, Z. Controversies in the prevention of spontaneous preterm birth in asymptomatic women: an evidence summary and expert opinion. BJOG: An International Journal of Obstetrics & Gynecology. 2020.Google Scholar
Torloni, MR, Betrán, AP, Daher, S, et al. Maternal BMI and preterm birth: A systematic review of the literature with meta-analysis. The Journal of Maternal-Fetal & Neonatal Medicine. 2009. 22(11):957–970.Google Scholar
Hobel, C, and Culhane, J. Role of psychosocial and nutritional stress on poor pregnancy outcome. Journal of Nutrition. 2003, 133(5 Suppl 2):1709s–1717s.Google Scholar
Williams, C, Fong, R, Murray, S, et al. Caesarean birth and risk of subsequent preterm birth: A retrospective cohort study. BJOG: An International Journal of Obstetrics & Gynecology. 2020.Google Scholar
Murray, SR, Stock, SJ, Cowan, S, et al. Spontaneous preterm birth prevention in multiple pregnancy. The Obstetrician & Gynaecologist. 2018, 20(1):57–63.Google Scholar
Goldenberg, RL, Hauth, JC, and Andrews, WW. Intrauterine infection and preterm delivery. New England Journal of Medicine. 2000, 342(20):1500–1507.Google Scholar
Chang, E. Preterm birth and the role of neuroprotection. BMJ: British Medical Journal. 2015, 350:g6661.Google Scholar
Gravett, MG, Witkin, SS, Haluska, GJ, et al. An experimental model for intraamniotic infection and preterm labor in rhesus monkeys. American Journal of Obstetrics and Gynecology. 1994, 171(6):1660–1667.Google Scholar
Saigal, S, and Doyle, LW. An overview of mortality and sequelae of preterm birth from infancy to adulthood. The Lancet. 2008, 371(9608):261–269.Google Scholar
Crump, C, Sundquist, J, and Sundquist, K. Preterm delivery and long term mortality in women: National cohort and co-sibling study. BMJ. 2020, 370:m2533.Google Scholar
Shynlova, O, Nadeem, L, Zhang, J, et al. Myometrial activation: Novel concepts underlying labor. Placenta. 2020, 92:28–36.Google Scholar
Smith, R, Smith, JI, Shen, X, et al. Patterns of plasma corticotropin-releasing hormone, progesterone, estradiol, and estriol change and the onset of human labor. The Journal of Clinical Endocrinology and Metabolism. 2009, 94(6):2066–2074.Google Scholar
Singh, S, Daga, MK, Kumar, A, et al. Role of oestrogen and its receptors in HEV‐associated feto‐maternal outcomes. Liver International. 2019, 39(4):633–639.Google Scholar
Menon, R, Bonney, EA, Condon, J, et al. Novel concepts on pregnancy clocks and alarms: Redundancy and synergy in human parturition. Human Reproduction Update. 2016, 22(5):535–560.Google Scholar
Mendelson, CR, Gao, L, and Montalbano, AP. Multifactorial regulation of myometrial contractility during pregnancy and parturition. Frontiers in Endocrinology. 2019, 10(714): 1–17.Google Scholar
Welsh, T, Johnson, M, Yi, L, et al. Estrogen receptor (ER) expression and function in the pregnant human myometrium: estradiol via ERα activates ERK1/2 signaling in term myometrium. Journal of Endocrinology. 2012, 212(2):227–238.Google Scholar
Makieva, S, Saunders, PTK, and Norman, JE. Androgens in pregnancy: Roles in parturition. Human Reproduction Update. 2014, 20(4):542–559.Google Scholar
Meakin, AS, and Clifton, VL. Review: Understanding the role of androgens and placental AR variants: Insight into steroid-dependent fetal-placental growth and development. Placenta. 2019, 84:63–68.Google Scholar
Carlsen, SM, Jacobsen, G, and Romundstad, P. Maternal testosterone levels during pregnancy are associated with offspring size at birth. European Journal of Endocrinology. 2006, 155(2):365–370.Google Scholar
He, X, Wang, P, Wang, Z, et al. Thyroid antibodies and risk of preterm delivery: A meta-analysis of prospective cohort studies. European Journal of Endocrinology. 2012, 167(4):455–464.Google Scholar
Thangaratinam, S, Tan, A, Knox, E, et al. Association between thyroid autoantibodies and miscarriage and preterm birth: Meta-analysis of evidence. BMJ. 2011, 342:d2616.Google Scholar
Korevaar, TIM, Derakhshan, A, Taylor, PN, et al. Association of thyroid function test abnormalities and thyroid autoimmunity with preterm birth: A systematic review and meta-analysis. JAMA: The Journal of the American Medical Association. 2019, 322(7):632–641.Google Scholar
Rao, M, Zeng, Z, Zhou, F, et al. Effect of levothyroxine supplementation on pregnancy loss and preterm birth in women with subclinical hypothyroidism and thyroid autoimmunity: A systematic review and meta-analysis. Human Reproduction Update. 2019, 25(3):344–361.Google Scholar
Chen, Y, Holzman, C, Chung, H, et al. Levels of maternal serum corticotropin-releasing hormone (CRH) at midpregnancy in relation to maternal characteristics. Psychoneuroendocrinology. 2010, 35(6):820–832.Google Scholar
You, X, Liu, J, Xu, C, et al. Corticotropin-Releasing Hormone (CRH) promotes inflammation in human pregnant myometrium: The evidence of CRH initiating parturition? The Journal of Clinical Endocrinology and Metabolism. 2014, 99(2):E199–E208.Google Scholar
Shynlova, O, Lee, Y-H, Srikhajon, K, et al. Physiologic uterine inflammation and labor onset: Integration of endocrine and mechanical signals. Reproductive Sciences. 2013, 20(2):154–167.Google Scholar
Menon, R, Behnia, F, Polettini, J, et al. Placental membrane aging and HMGB1 signaling associated with human parturition. Aging. 2016, 8(2):216–230.Google Scholar
Padron, JG, Saito Reis, CA, and Kendal-Wright, CE. The role of danger associated molecular patterns in human fetal membrane weakening. Frontiers in Physiology. 2020, 11(602): 1–18.Google Scholar
Romero, R, Espinoza, J, Gonçalves, LF, et al. Inflammation in preterm and term labour and delivery. Seminars in Fetal and Neonatal Medicine. 2006, 11(5):317–326.Google Scholar
Berghella, V, and Saccone, G. Cervical assessment by ultrasound for preventing preterm delivery. Cochrane Library: Cochrane Reviews. 2019, 9(9):Cd007235.Google Scholar
Iams, JD, Romero, R, Culhane, JF, et al. Primary, secondary, and tertiary interventions to reduce the morbidity and mortality of preterm birth. The Lancet. 2008, 371(9607):164–175.Google Scholar
National Collaborating Centre for Ws, Children’s H. National Institute for Health and Care Excellence: Clinical Guidelines. Preterm Labour and Birth. London: National Institute for Health and Care Excellence (UK) National Collaborating Centre for Women’s and Children’s Health; 2015.Google Scholar
Owen, J, Yost, N, Berghella, V, et al. Mid-trimester endovaginal sonography in women at high risk for spontaneous preterm birth. JAMA. 2001, 286(11):1340–1348.Google Scholar
Berghella, V, and Saccone, G. Fetal fibronectin testing for reducing the risk of preterm birth. Cochrane Database of Systematic Reviews. 2019, 7.Google Scholar
Excellence NIfHaC. Biomarker Tests to Help Diagnose Preterm Labour in Women with Intact Membranes. London: NICE; 2018.Google Scholar
Heng, Y, Pennell, C, Chua, HN, et al. Whole blood gene expression profile associated with spontaneous preterm birth in women with threatened preterm labor. PLoS ONE. 2014, 9:e96901.Google Scholar
Heng, YJ, Pennell, CE, McDonald, SW, et al. Maternal whole blood gene expression at 18 and 28 weeks of gestation associated with spontaneous preterm birth in asymptomatic women. PLoS ONE. 2016, 11(6):e0155191.Google Scholar
Gibb, D, and Saridogan, E. The role of transabdominal cervical cerclage techniques in maternity care. The Obstetrician & Gynaecologist. 2016, 18(2):117–125.Google Scholar
Dodd, JM, Jones, L, Flenady, V, et al. Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth. Cochrane Database of Systematic Reviews. 2013, (7):CD004947.Google Scholar
Norman, JE, Marlow, N, Messow, C-M, et al. Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): A multicentre, randomised, double-blind trial. The Lancet. 2016, 387(10033):2106–2116.Google Scholar
Berghella, V, Odibo, AO, To, MS, et al. Cerclage for short cervix on ultrasonography: Meta-Analysis of trials using individual patient-level data. Obstetrics & Gynecology. 2005, 106(1).Google Scholar
Ehsanipoor, RM, Seligman, NS, Saccone, G, et al. Physical examination-indicated cerclage: A systematic review and meta-analysis. Obstet Gynecol. 2015, 126(1):125–135.Google Scholar
Hermans, FJR, Schuit, E, Bekker, MN, et al. Cervical pessary after arrested preterm labor: A randomized controlled trial. Obstetrics & Gynecology. 2018, 132(3).Google Scholar
Haas, DM, Caldwell, DM, Kirkpatrick, P, et al. Tocolytic therapy for preterm delivery: Systematic review and network meta-analysis. BMJ: British Medical Journal. 2012, 345:e6226.Google Scholar
Caritis, S. Adverse effects of tocolytic therapy. BJOG: An International Journal of Obstetrics & Gynaecology. 2005, 112(s1):74–78.Google Scholar
McGoldrick, E, Stewart, F, Parker, R, et al. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews. 2020, 12(12):CD004454.Google Scholar
ACOG. Committee Opinion No. 713: Antenatal Corticosteroid Therapy for Fetal Maturation. Obstetrics and Gynecology. 2017, 130(5):1159.Google Scholar
Doyle, LW, Crowther, CA, Middleton, P, et al. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database of Systematic Reviews. 2009, (1):CD004661.Google Scholar
Elovitz, MA, and Mrinalini, C. Animal models of preterm birth. Trends in Endocrinology and Metabolism. 2004, 15(10):479–487.Google Scholar
Faro, J, Romero, R, Schwenkel, G, et al. Intra-amniotic inflammation induces preterm birth by activating the NLRP3 inflammasome. Biology of Reproduction. 2019, 100(5):1290–1305.Google Scholar
Coleman, M, Orvis, A, Wu, T-Y, et al. A broad spectrum chemokine inhibitor prevents preterm labor but not microbial invasion of the amniotic cavity or neonatal morbidity in a non-human primate model. Frontiers in Immunology. 2020, 11(770).Google Scholar
Shynlova, O, and Lye, SJ. Regulation of parturition. In: Croy, BA, Yamada, AT, DeMayo, FJ, Adamson, SL (Eds), The Guide to Investigation of Mouse Pregnancy. 2014; 373–389. Boston: Academic Press.Google Scholar
Bryan, FM, and Michael, JT. Are animal models relevant to key aspects of human parturition? American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2009, 297(3):525–545.Google Scholar
Dinny Graham, J, and Clarke, CL. Physiological action of progesterone in target tissues. Endocrine Reviews. 1997, 18(4):502–519.Google Scholar
Holt, R, Timmons, BC, Akgul, Y, et al. The molecular mechanisms of cervical ripening differ between term and preterm birth. Endocrinology. 2011, 152(3):1036–1046.Google Scholar
Motomura, K, Romero, R, Garcia-Flores, V, et al. The alarmin interleukin-1α causes preterm birth through the NLRP3 inflammasome. Molecular Human Reproduction. 2020, 26(9):712–726.Google Scholar
Hirsch, E, and Wang, H. The molecular pathophysiology of bacterially induced preterm labor: Insights from the murine model. The Journal of the Society for Gynecologic Investigation: JSGI. 2005, 12(3):145–155.Google Scholar
MacIntyre, DA, Sykes, L, Teoh, TG, et al. Prevention of preterm labour via the modulation of inflammatory pathways. The Journal of Maternal-Fetal & Neonatal Medicine. 2012, 25(Suppl 1):17–20.Google Scholar
Mulligan, MS, and Ward, PA. Immune complex-induced lung and dermal vascular injury. Differing requirements for tumor necrosis factor-alpha and IL-1. The Journal of Immunology. 1992, 149(1):331–339.Google Scholar
Elovitz, MA, Brown, AG, Breen, K, et al. Intrauterine inflammation, insufficient to induce parturition, still evokes fetal and neonatal brain injury. International Journal of Developmental Neuroscience. 2011, 29(6):663–671.Google Scholar
Gross, GA, Imamura, T, Luedke, C, et al. Opposing actions of prostaglandins and oxytocin determine the onset of murine labor. Proceedings of the National Academy of Sciences (PNAS). 1998, 95(20):11875–11879.Google Scholar
Wang, H, Xie, H, and Dey, SK. Loss of cannabinoid receptor CB1 induces preterm birth. PLoS ONE. 2008, 3(10):1–8.Google Scholar
Hirsch, E, Filipovich, Y, and Mahendroo, M. Signaling via the type I IL-1 and TNF receptors is necessary for bacterially induced preterm labor in a murine model. American Journal of Obstetrics and Gynecology. 2006, 194(5):1334–1340.Google Scholar
Gonzalez, JM, Romero, R, and Girardi, G. Comparison of the mechanisms responsible for cervical remodeling in preterm and term labor. Journal of Reproductive Immunology. 2012, 97(1):112–119.Google Scholar
Soloff, MS, Jeng, Y-J, Izban, MG, et al. Effects of progesterone treatment on expression of genes involved in uterine quiescence. Reproductive Sciences. 2011, 18(8):781–797.Google Scholar
Shynlova, O, Nadeem, L, Dorogin, A, et al. The selective progesterone receptor modulator, Promegestone, delays term parturition and prevents infection-mediated preterm birth in mice. AJOG. 2022, 226(2):249.e1–249.e21.Google Scholar
Shynlova, O, Dorogin, A, Li, Y, et al. Inhibition of infection-mediated preterm birth by administration of broad spectrum chemokine inhibitor in mice. Journal of Cellular and Molecular Medicine. 2014, 18(9):1816–1829.Google Scholar
Stock, SJ, Thomson, AJ, Papworth, S; the Royal College of Obstetricians, Gynaecologists. Antenatal corticosteroids to reduce neonatal morbidity and mortality. BJOG: An International Journal of Obstetrics & Gynecology. 2022.Google Scholar
References
Moleti, M, Trimarchi, F, and Vermiglio, F. Thyroid physiology in pregnancy. Endocr Pract. 2014, 6: 589–596.Google Scholar
Taylor, PN, Albrecht, D, Scholz, A, et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol. 2018, 14: 301–316.Google Scholar
Garmendia Madariaga, A, Santos Palacios, S, Guillén-Grima, F, et al. The incidence and prevalence of thyroid dysfunction in Europe. J Clin Endocrinol Metab. 2014, 99: 923–931.Google Scholar
Carlé, A, Andersen, SL, Boelaert, K, et al. Subclinical thyrotoxicosis: Prevalence, causes and choice of therapy. Eur J Endocrinol. 2017, 176: R325–37.Google Scholar
Bartalena, L. Diagnosis and management of Graves’ disease: A global overview. Nat Rev Endocrinol. 2013, 9: 724–734.Google Scholar
Carlé, A, Bulow Pedersen, I, Knudsen, N, et al. Epidemiology of subtypes of hyperthyroidism in Denmark: A population-based study. Eur J Endocrinol. 2011, 164: 801–809.Google Scholar
Cooper, DS, and Laurberg, P. Hyperthyroidism in pregnancy. Lancet Diabetes Endocrinol. 2013, 1: 238–249.Google Scholar
Kahaly, GJ. Management of Graves thyroidal and extrathyroidal disease: An update. J Clin Endocrinol Metab. 2020, 105: 3704–3720.Google Scholar
Abraham-Nordling, M, Bystrom, K, Torring, O, et al. Incidence of hyperthyroidism in Sweden. Eur J Endocrinol. 2011, 165: 899–905.Google Scholar
Korelitz, JJ, McNally, DN, Masters, MN, et al. Prevalence of thyrotoxicosis, antithyroid medication use, and complications among pregnant women in the United States. Thyroid. 2013, 23: 758–765.Google Scholar
Korevaar, TIM, Medici, M, Visser, TJ, et al. Thyroid disease in pregnancy: new insights in diagnosis and clinical management. Nat Rev Endocrinol. 2017, 13: 610–622.Google Scholar
Rodien, P, Bremont, C, Sanson, ML, et al. Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. N Engl J Med. 1998, 339: 1823–1826.Google Scholar
Lee, RH, Spencer, CA Mestman, JH, et al. Free T4 immunoassays are flawed during pregnancy. Am J Obstet Gynecol. 2009; 200: 260. e1–6.Google Scholar
Bartalena, L, and Fatourechi, V. Extrathyroidal manifestations of Graves’ disease: a 2014 update. J Endocrinol Invest. 2014, 37: 691–700.Google Scholar
Yoshihara, A, Noh, JY, Mukasa, K, et al. Serum human chorionic gonadotropin levels and thyroid hormone levels in gestational transient thyrotoxicosis: Is the serum hCG level useful for differentiating between active Graves’ disease and GTT? Endocr J. 2015, 62: 557–560.Google Scholar
Alexander, EK, Pearce, EN, Brent, GA, et al. 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and post-partum. Thyroid. 2017, 27: 315–389.Google Scholar
Medici, M, Timmermans, M, Visser, W, et al. Maternal thyroid hormone parameters during early pregnancy and birth weight: the Generation R Study. J Clin Endocrinol Metab. 2013, 98: 59–66.Google Scholar
Korevaar, TIM, Muetzel, R, Medici, M, et al. Association of maternal thyroid function during early pregnancy with offspring IQ and brain morphology in childhood: a population-based prospective cohort study. Lancet Diabetes Endocrinol. 2016, 4: 35–43.Google Scholar
Mannisto, T, Mendola, P, Grewal, J, et al. Thyroid diseases and adverse pregnancy outcomes in a contemporary US cohort. J Clin Endocrinol Metab. 2013, 98: 2725–2733.Google Scholar
Andersen, SL, Laurberg, P, Wu, CS, et al. Attention deficit hyperactivity disorder and autism spectrum disorder in children born to mothers with thyroid disorders: A Danish nationwide cohort study. BJOG. 2014, 121: 1365–1374.Google Scholar
Andersen, SL, Olsen, J, Wu, CS, et al. Spontaneous abortion, stillbirth and hyperthyroidism: A Danish population-based study. Eur Thyroid J. 2014, 3: 164–172.Google Scholar
Andersen, Sl, Olsen, J, and Laurberg, P. Foetal programming by maternal thyroid disease. Clin Endocrinol (Oxf). 2015, 83: 751–758.Google Scholar
Kahaly, GJ, Bartalena, L, Hegedus, L, et al. 2018 European Thyroid Association guideline for the management of Graves’ hyperthyroidism. Eur Thyroid J. 2018, 7: 167–186.Google Scholar
Bartalena, L, Chiovato, L, and Vitti, P. Management of hyperthyroidism due to Graves’ disease: Frequently asked questions and answers (if any). J Endocrinol Invest. 2016, 39: 1105–1114.Google Scholar
Andersen, SL, Olsen, J, and Laurberg, P. Antithyroid drug side effects in the population and in pregnancy. J Clin Endocrinol Metab. 2016, 101: 1606–1614.Google Scholar
Andersen, SL, Olsen, J, Wu, CS, et al. Birth defects after early pregnancy use of antithyroid drugs: A Danish nationwide study. J Clin Endocrinol Metab. 2013, 98: 4373–4381.Google Scholar
Tonacchera, M, Chiovato, L, Bartalena, L, et al. Treatment of Graves’ disease with thionamides: A position paper on indications and safety in pregnancy. J Endocrinol Invest. 2020, 43: 257–265.Google Scholar
Rotondi, M, Cappelli, C, Pirali, B, et al. The effect of pregnancy on subsequent relapse from Graves’ disease after a successful course of antithyroid drug therapy. J Clin Endocrinol Metab. 2008, 93: 3985–3988.Google Scholar
Shan, Z, and Teng, W. Thyroid hormone therapy of hypothyroidism in pregnancy. Endocrine. 2019, 66: 35–42.Google Scholar
Teng, W, Shan, Z, Patil-Sisodia, K, et al. Hypothyroidism in pregnancy. Lancet Diabetes Endocrinol. 2013, 1: 228–237.Google Scholar
Zimmermann, MB, Burgi, H, and Hurrell, R. Iron deficiency predicts poor maternal thyroid status during pregnancy. J Clin Endocrinol Metab. 2007, 92: 3436–3440.Google Scholar
Lazarus, JH, Brown, RS, Daumerie, C, et al. 2014 European Thyroid Association guidelines for the management of subclinical hypothyroidism in pregnancy and in children. Eur Thyroid J. 2014, 3: 76–94.Google Scholar
Stagnaro-Green, A, Abalovich, M, Alexander, E, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011, 21: 1081–1125.Google Scholar
Haddow, JE, Palomaki, GE, Allan, WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med. 1999, 341: 549–555.Google Scholar
Ge, GM, Leung, MTY, Man, KKC, et al. Maternal thyroid dysfunction during pregnancy and the risk of adverse outcomes in the offspring: A systematic review and meta-analysis. J Clin Endocrinol Metab. 2020, 105(12): dgaa555. https://doi.org/10.1210/clinem/dgaa555.Google Scholar
Maraka, S, Singh Ospina, NM, O’Keefe, DT, et al. Subclinical hypothyroidism in pregnancy: A systematic review and meta-analysis. Thyroid. 2016, 26: 580–590.Google Scholar
Derakhshan, A, Peeters, RP, Taylor, PN, et al. Association of maternal thyroid function with birthweight: A systematic review and individual-participant data meta-analysis. Lancet Diabetes Endocrinol. 2020, 8: 501–510.Google Scholar
Rotondi, M, Chiovato, L, Pacini, F, et al. Management of subclinical hypothyroidism in pregnancy: A comment from the Italian Society of Endocrinology and the Italian Thyroid Association to the 2017 American Thyroid Association guidelines- “The Italian way”. Thyroid. 2018, 551–555.Google Scholar
Lazarus, JH, Bestwick, JP, Channon, S, et al. Antenatal thyroid screening and childhood cognitive function. N Engl J Med. 2012, 366: 493–501.Google Scholar
Casey, BM, Thom, EA, Peaceman, AM, et al. Treatment of subclinical hypothyroidism or hypothyroxinemia in pregnancy. N Engl J Med. 2017, 376: 815–825.Google Scholar
Taylor, PN, Muller, I, Nana, M, et al. Indications for treatment of subclinical hypothyroidism and isolated hypothyroxinemia in pregnancy. Best Pract Res Clin Endocrinol Metab. 2020. https://doi.org/10.1016/j.beem.2020.101436.Google Scholar
Stagnaro-Green, A, Dong, A, and Stephenson, MD. Universal screening for thyroid disease during pregnancy should be performed. Best Pract Res Clin Endocrinol Metab. 2019. https://doi.org/10.1016/j.beem.2019.101320.Google Scholar
Hollowell, JG, Staehling, NW, Flanders, WD, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002, 87: 489–499.Google Scholar
De Leo, S, and Pearce, EN. Autoimmune thyroid disease during pregnancy. Lancet Diabetes Endocrinol. 2018, 6: 575–586.Google Scholar
Lau, L, Benham, JL, Lemieux, P, et al. Impact of levothyroxine in women with thyroid antibodies on pregnancy outcomes: A systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2021, 11(2): e043751. https://doi.org/10.1136/bmjopen-2020-043751.Google Scholar
van den Boogard, E, Vissenberg, R, Landa, JA, et al. Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: A systematic review. Hum Reprod Update. 2011, 17: 605–619.Google Scholar
Busnelli, A, Paffoni, A, Fedele, L, and et al. The impact of thyroid autoimmunity on IVF/ICSI outcome: A systematic review and meta-analysis. Hum Reprod Update. 2016, 22: 793–794.Google Scholar
Poppe, K, Bisschop, P, Fugazzola, L, et al. 2021 European Thyroid Association guideline on thyroid disorders prior to and during assisted reproduction. Eur Thyroid J. 2020; 9: 281–295.Google Scholar
Stagnaro-Green, A, Schwartz, A, Gismondi, R, et al. High rate of persistent hypothyroidism in a large-scale prospective study of postpartum thyroiditis in Southern Italy. J Clin Endocrinol Metab. 2011; 96: 652–657.Google Scholar
Stagnaro-Green, A. Approach to the patient with postpartum thyroiditis. J Clin Endocrinol Metab. 2012, 97: 334–342.Google Scholar
References
Staff, AC, Redman, CW, Williams, D, et al. Pregnancy and long-term maternal cardiovascular health: Progress through harmonization of research cohorts and biobanks. Hypertension. 2016, 67:251–260.Google Scholar
Stojanovska, V, Scherjon, SA, and Plosch, T. Preeclampsia as modulator of offspring health. Biol Reprod. 2016, 94:53.Google Scholar
Piering, WF, Garancis, JG, Becker, CG, et al. Preeclampsia related to a functioning extrauterine placenta: Report of a case and 25-year follow-up. Am J Kidney Dis. 1993, 21:310–313.Google Scholar
Brittain, PC, and Bayliss, P. Partial hydatidiform molar pregnancy presenting with severe preeclampsia prior to twenty weeks gestation: A case report and review of the literature. Mil Med. 1995, 160:42–44.Google Scholar
Chesley, LC. Hypertensive disorders of pregnancy. In. New York: Appleton-Century-Crofts, 1978.Google Scholar
Roberts, JM, Taylor, RN, Musci, TJ, et al. Preeclampsia: An endothelial cell disorder. Am J Obstet Gynecol. 1989, 161:1200–1204.Google Scholar
Redman, CW, Sacks, GP, and Sargent, IL. Preeclampsia: An excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 1999, 180:499–506.Google Scholar
Redman, CWG, Staff, AC, and Roberts, JM. Syncytiotrophoblast stress in preeclampsia: The convergence point for multiple pathways. Am J Obstet Gynecol. 2020, 08:08.Google Scholar
Salas, SP, Marshall, G, Gutierrez, BL, et al. Time course of maternal plasma volume and hormonal changes in women with preeclampsia or fetal growth restriction. Hypertension. 2006, 47:203–208.Google Scholar
Duvekot, JJ, Cheriex, EC, Pieters, FA, et al. Early pregnancy changes in hemodynamics and volume homeostasis are consecutive adjustments triggered by a primary fall in systemic vascular tone. Am J Obstet Gynecol. 1993, 169:1382–1392.Google Scholar
Oelkers, WK. Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure. Steroids. 1996, 61:166–171.Google Scholar
Van Buren, GA, Yang, DS, and Clark, KE. Estrogen-induced uterine vasodilatation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am J Obstet Gynecol. 1992, 167:828–833.Google Scholar
Johnson, ML, Grazul-Bilska, AT, Redmer, DA, et al. Effects of estradiol-17beta on expression of mRNA for seven angiogenic factors and their receptors in the endometrium of ovariectomized (OVX) ewes. Endocrine. 2006, 30:333–342.Google Scholar
Miller, VM, and Vanhoutte, PM. Progesterone and modulation of endothelium-dependent responses in canine coronary arteries. Am J Physiol. 1991, 261:R1022–1027.Google Scholar
Berkane, N, Liere, P, Oudinet, JP, et al. From pregnancy to preeclampsia: A key role for estrogens. Endocr Rev. 2017, 38:123–144.Google Scholar
Magness, RR, Sullivan, JA, Li, Y, et al. Endothelial vasodilator production by uterine and systemic arteries. VI. Ovarian and pregnancy effects on eNOS and NO(x). Am J Physiol Heart Circ Physiol. 2001, 280:H1692–1698.Google Scholar
Nelson, SH, Steinsland, OS, Wang, Y, et al. Increased nitric oxide synthase activity and expression in the human uterine artery during pregnancy. Circ Res. 2000, 87:406–411.Google Scholar
Salom, JB, Burguete, MC, Perez-Asensio, FJ, et al. Relaxant effects of 17-beta-estradiol in cerebral arteries through Ca(2+) entry inhibition. J Cereb Blood Flow Metab. 2001, 21:422–429.Google Scholar
Bausero, P, Ben-Mahdi, M, Mazucatelli, J, et al. Vascular endothelial growth factor is modulated in vascular muscle cells by estradiol, tamoxifen, and hypoxia. Am J Physiol Heart Circ Physiol. 2000, 279:H2033–2042.Google Scholar
Mueller, MD, Vigne, JL, Minchenko, A, et al. Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta. Proc Natl Acad Sci U S A. 2000, 97:10972–10977.Google Scholar
Shimodaira, M, Nakayama, T, Sato, I, et al. Estrogen synthesis genes CYP19A1, HSD3B1, and HSD3B2 in hypertensive disorders of pregnancy. Endocrine. 2012, 42:700–707.Google Scholar
Sharifzadeh, F, Kashanian, M, and Fatemi, F. A comparison of serum androgens in pre-eclamptic and normotensive pregnant women during the third trimester of pregnancy. Gynecol Endocrinol. 2012, 28:834–836.Google Scholar
Kumar, P, Luo, Y, Tudela, C, et al. The c-Myc-regulated microRNA-17~92 (miR-17~92) and miR-106a~363 clusters target hCYP19A1 and hGCM1 to inhibit human trophoblast differentiation. Mol Cell Biol. 2013, 33:1782–1796.Google Scholar
Stamilio, DM, Sehdev, HM, Morgan, MA, et al. Can antenatal clinical and biochemical markers predict the development of severe preeclampsia? Am J Obstet Gynecol. 2000;182:589–594.Google Scholar
Steier, JA, Ulstein, M, and Myking, OL. Human chorionic gonadotropin and testosterone in normal and preeclamptic pregnancies in relation to fetal sex. Obstet Gynecol. 2002, 100:552–556.Google Scholar
Kumar, S, Gordon, GH, Abbott, DH, et al. Androgens in maternal vascular and placental function: implications for preeclampsia pathogenesis. Reproduction. 2018, 156:R155–R167.Google Scholar
Shao, X, Liu, Y, Liu, M, et al. Testosterone represses estrogen signaling by upregulating miR-22: A mechanism for imbalanced steroid hormone production in preeclampsia. Hypertension. 2017, 69:721–730.Google Scholar
Laivuori, H, Kaaja, R, Rutanen, EM, et al. Evidence of high circulating testosterone in women with prior preeclampsia. J Clin Endocrinol Metab. 1998, 83:344–347.Google Scholar
Pion, R, Jaffe, R, Eriksson, G, et al. Studies on the metabolism of C-21 steroids in the human foeto-placental unit. I. Formation of a beta-unsaturated 3-ketones in midterm placentas perfused in situ with pregnenolone and 17-alpha-hydroxypregnenolone. Acta Endocrinol (Copenh). 1965, 48:234–248.Google Scholar
Rosing, U, and Carlstrom, K. Serum levels of unconjugated and total oestrogens and dehydroepiandrosterone, progesterone and urinary oestriol excretion in pre-eclampsia. Gynecol Obstet Invest. 1984, 18:199–205.Google Scholar
Tamimi, R, Lagiou, P, Vatten, LJ, et al. Pregnancy hormones, pre-eclampsia, and implications for breast cancer risk in the offspring. Cancer Epidemiol Biomarkers Prev. 2003, 12:647–650.Google Scholar
Schoof, E, Girstl, M, Frobenius, W, et al. Course of placental 11beta-hydroxysteroid dehydrogenase type 2 and 15-hydroxyprostaglandin dehydrogenase mRNA expression during human gestation. Eur J Endocrinol. 2001, 145:187–192.Google Scholar
Aufdenblatten, M, Baumann, M, Raio, L, et al. Prematurity is related to high placental cortisol in preeclampsia. Pediatr Res. 2009, 65:198–202.Google Scholar
Cole, LA. Biological functions of hCG and hCG-related molecules. Reprod Biol Endocrinol. 2010, 8:102.Google Scholar
Zygmunt, M, Herr, F, Keller-Schoenwetter, S, et al. Characterization of human chorionic gonadotropin as a novel angiogenic factor. J Clin Endocrinol Metab. 2002, 87:5290–5296.Google Scholar
Barjaktarovic, M, Korevaar, TIM, Jaddoe, VWV, et al. Human chorionic gonadotropin and risk of pre-eclampsia: prospective population-based cohort study. Ultrasound Obstet Gynecol. 2019, 54:477–483.Google Scholar
Levine, RJ, Lam, C, Qian, C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006, 355:992–1005.Google Scholar
Levine, RJ, Maynard, SE, Qian, C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004, 350:672–683.Google Scholar
Campbell, EA, Linton, EA, Wolfe, CD, et al. Plasma corticotropin-releasing hormone concentrations during pregnancy and parturition. J Clin Endocrinol Metab. 1987, 64:1054–1059.Google Scholar
Chau, K, Hennessy, A, and Makris, A. Placental growth factor and pre-eclampsia. J Hum Hypertens. 2017, 31:782–786.Google Scholar
Thadhani, R, Hagmann, H, Schaarschmidt, W, et al. Removal of soluble fms-like tyrosine kinase-1 by dextran sulfate apheresis in preeclampsia. J Am Soc Nephrol. 2016, 27:903–913.Google Scholar
Salustiano, EM, De Pinho, JC, Provost, K, et al. Maternal serum hormonal factors in the pathogenesis of preeclampsia. Obstet Gynecol Surv. 2013, 68:141–150.Google Scholar
Conrad, KP. Emerging role of relaxin in the maternal adaptations to normal pregnancy: Implications for preeclampsia. Semin Nephrol. 2011, 31:15–32.Google Scholar
Conrad, KP, and Baker, VL. Corpus luteal contribution to maternal pregnancy physiology and outcomes in assisted reproductive technologies. Am J Physiol Regul Integr Comp Physiol. 2013, 304:R69–72.Google Scholar
Post Uiterweer, ED, Koster, MPH, Jeyabalan, A, et al. Circulating pregnancy hormone relaxin as a first trimester biomarker for preeclampsia. Pregnancy Hypertens. 2020, 22:47–53.Google Scholar
Korevaar, TIM, Medici, M, Visser, TJ, et al. Thyroid disease in pregnancy: New insights in diagnosis and clinical management. Nat Rev Endocrinol. 2017, 13:610–622.Google Scholar
Berta, E, Lengyel, I, Halmi, S, et al. Hypertension in thyroid disorders. Front Endocrinol. 2019, 10:482.Google Scholar
Wilson, KL, Casey, BM, McIntire, DD, et al. Subclinical thyroid disease and the incidence of hypertension in pregnancy. Obstet Gynecol. 2012, 119:315–320.Google Scholar
Gant, NF, Daley, GL, Chand, S, et al. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest. 1973, 52:2682–2689.Google Scholar
Yang, J, Shang, JY, Zhang, SL, et al. The role of the renin-angiotensin-aldosterone system in preeclampsia: genetic polymorphisms and microRNA. J Mol Endocrinol. 2013, 50:R53–R66.Google Scholar
Xia, Y, Kellems, RE, Xia, Y, et al. Angiotensin receptor agonistic autoantibodies and hypertension: Preeclampsia and beyond. Circ Res. 2013, 113:78–87.Google Scholar
Chang, Y, and Wei, W. Angiotensin II in inflammation, immunity and rheumatoid arthritis. Clin Exper Immunol. 2015, 179:137–145.Google Scholar
Chen, T-H, Wang, J-F, Chan, P, et al. Angiotensin II stimulates hypoxia-inducible factor 1alpha accumulation in glomerular mesangial cells. Ann NY Acad Sci. 2005, 1042:286–293.Google Scholar
Zhou, CC, Ahmad, S, Mi, T, et al. Angiotensin II induces soluble fms-Like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy. Circ Res. 2007, 100:88–95.Google Scholar
Carey, RM. Update on angiotensin AT2 receptors. Curr Opin Nephrol Hypertens. 2017, 26:91–96.Google Scholar
Wu, C, Lu, H, Cassis, LA, et al. Molecular and pathophysiological features of angiotensinogen: A mini review. N Am J Med Sci. 2011, 4:183–190.Google Scholar
Ichihara, A, and Yatabe, MS. The (pro)renin receptor in health and disease. Nat Rev Nephrol. 2019, 15:693–712.Google Scholar
Gathiram, P, and Moodley, J. The role of the renin-angiotensin-aldosterone system in preeclampsia: A review. Curr Hypertens Rep. 2020, 22:89.Google Scholar
Hladunewich, MA, Kingdom, J, Odutayo, A, et al. Postpartum assessment of the renin angiotensin system in women with previous severe, early-onset preeclampsia. J Clin Endocrinol Metab. 2011, 96:3517–3524.Google Scholar
Saxena, AR, Karumanchi, SA, Brown, NJ, et al. Increased sensitivity to angiotensin II is present postpartum in women with a history of hypertensive pregnancy. Hypertension. 2010, 55:1239–1245.Google Scholar
Vinnakota, S, and Chen, HH. The importance of natriuretic peptides in cardiometabolic diseases. J Endocr Soc. 2020, 4:bvaa052.Google Scholar
Thomsen, JK, Fogh-Andersen, N, and Jaszczak, P. Atrial natriuretic peptide, blood volume, aldosterone, and sodium excretion during twin pregnancy. Acta Obstet. Gynecologica Scand. 1994, 73:14–20.Google Scholar
Yoshimura, T, Yoshimura, M, Yasue, H, et al. Plasma concentration of atrial natriuretic peptide and brain natriuretic peptide during normal human pregnancy and the postpartum period. J Endocrinol. 1994, 140:393–397.Google Scholar
Adam, Malatyalio, Gbreve, lu, Alvur, Kokcu, et al. Plasma atrial natriuretic peptide levels in preeclampsia and eclampsia. J Matern Fetal Investig. 1998, 8:85–88.Google Scholar
Franz, MB, Andreas, M, Schiessl, B, et al. NT-proBNP is increased in healthy pregnancies compared to non-pregnant controls. Acta Obstet Gynecol Scand. 2009, 88:234–237.Google Scholar
Li, H, Zhang, Y, and Wu, Q. Role of corin in the regulation of blood pressure. Curr Opin Nephrol Hyperten. 2017, 26:67–73.Google Scholar
Yan, W, Sheng, N, Seto, M, et al. Corin, a mosaic transmembrane serine protease encoded by a novel cDNA from human heart. J Biol Chem. 1999, 274:14926–14935.Google Scholar
Cui, Y, Wang, W, Dong, N, et al. Role of corin in trophoblast invasion and uterine spiral artery remodelling in pregnancy. Nature. 2012, 484:246–250.Google Scholar
Stepanian, A, Alcais, A, de Prost, D, et al. Highly significant association between two common single nucleotide polymorphisms in CORIN gene and preeclampsia in caucasian women. PLoS ONE. 2014, 9.Google Scholar
Degrelle, SA, Chissey, A, Stepanian, A, et al. Placental overexpression of soluble CORIN in preeclampsia. Am J Pathol. 2020, 190:970–976.Google Scholar
Jadli, A, Ghosh, K, and Shetty, S. Is peripheral blood corin level clinically relevant for prediction of pre-eclampsia? Ultrasound Obstet Gynecol. 2015, 46:380.Google Scholar
Degrelle, SA, Chissey, A, Stepanian, A, et al. Placental overexpression of soluble CORIN in preeclampsia. Am J Pathol. 190:970–976.Google Scholar
Baird, RC, Li, S, Wang, H, et al. Pregnancy-associated cardiac hypertrophy in corin-deficient mice: Observations in a transgenic model of preeclampsia. Can J Cardiol. 2019, 35:68–76.Google Scholar
Rotondo, F, Butz, H, Syro, LV, et al. Arginine vasopressin (AVP): A review of its historical perspectives, current research and multifunctional role in the hypothalamo-hypophysial system. Pituitary. 2016, 19:345–355.Google Scholar
Christ-Crain, M. Vasopressin and Copeptin in health and disease. Rev Endocr Metab Disord. 2019, 20:283–294.Google Scholar
Santillan, MK, Santillan, DA, Scroggins, SM, et al. Vasopressin in preeclampsia: A novel very early human pregnancy biomarker and clinically relevant mouse model. Hypertension. 2014, 64:852–859.Google Scholar
Scroggins, SM, Santillan, DA, Lund, JM, et al. Elevated vasopressin in pregnant mice induces T-helper subset alterations consistent with human preeclampsia. Clin Sci. 2018, 132:419–436.Google Scholar
Bellos, I, Pergialiotis, V, Papapanagiotou, A, et al. Association between serum copeptin levels and preeclampsia risk: A meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2020, 250:66–73.Google Scholar
Asvold, BO, Vatten, LJ, Romundstad, PR, et al. Angiogenic factors in maternal circulation and the risk of severe fetal growth restriction. Am J Epidemiol. 2011, 173:630–639.Google Scholar
Palei, AC, Warrington, JP, and Granger, JP. The effect of placental ischemia-induced hypertension on circulating copeptin levels of pregnant rats. FASEB J. 2016, 30.Google Scholar
Matsuura, T, Shinohara, K, Iyonaga, T, et al. Prior exposure to placental ischemia causes increased salt sensitivity of blood pressure via vasopressin production and secretion in postpartum rats. J Hyperten. 2019, 37:1657–1667.Google Scholar
Yousif, D, Bellos, I, Penzlin, AI, et al. Autonomic dysfunction in preeclampsia: A systematic review. Front Neurol. 2019, 10:816.Google Scholar
Palacios, C, Kostiuk, LK, and Peña-Rosas, JP. Vitamin D supplementation for women during pregnancy. Cochrane Database Syst Rev. 2019, 7:Cd008873.Google Scholar
Langston-Cox, A, Marshall, SA, Lu, D, et al. Melatonin for the management of preeclampsia: A review. Antioxidants. 2021, 10:376.Google Scholar
Kapustin, RV, Drobintseva, AO, Alekseenkova, EN, et al. Placental protein expression of kisspeptin-1 (KISS1) and the kisspeptin-1 receptor (KISS1R) in pregnancy complicated by diabetes mellitus or preeclampsia. Arch Gynecol Obstet. 2020, 301:437–445.Google Scholar
Roberts, JM, Rich-Edwards, JW, McElrath, TF, et al. Subtypes of preeclampsia: Recognition and determining clinical usefulness. Hypertension. 2021, 77:1430–1441.Google Scholar
References
Rainey, WE, Rehman, KS, and Carr, BR. Fetal and maternal adrenals in human pregnancy. Obstet Gynecol Clin North Am. 2004, 31(4):817–835, x.Google Scholar
Duthie, L, and Reynolds, RM. Changes in the maternal hypothalamic-pituitary-adrenal axis in pregnancy and postpartum: Influences on maternal and fetal outcomes. Neuroendocrinology. 2013, 98(2):106–115.Google Scholar
Mastorakos, G, and Ilias, I. Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum. Ann N Y Acad Sci. 2003, 997:136–149.Google Scholar
Levin, G, Elchalal, U, and Rottenstreich, A. The adrenal cortex: Physiology and diseases in human pregnancy. Eur J Obstet Gynecol Reprod Biol. 2019, 240:139–143.Google Scholar
Lindsay, JR, and Nieman, LK. The hypothalamic-pituitary-adrenal axis in pregnancy: challenges in disease detection and treatment. Endocr Rev. 2005, 26(6):775–799.Google Scholar
Monticone, S, Auchus, RJ, and Rainey, WE. Adrenal disorders in pregnancy. Nat Rev Endocrinol. 2012, 8(11):668–678.Google Scholar
Soldin, OP, Guo, T, Weiderpass, E, et al. Steroid hormone levels in pregnancy and 1 year postpartum using isotope dilution tandem mass spectrometry. Fertil Steril. 2005, 84(3):701–710.Google Scholar
Jung, C, Ho, JT, Torpy, DJ, et al. A longitudinal study of plasma and urinary cortisol in pregnancy and postpartum. J Clin Endocrinol Metab. 2011, 96(5):1533–1540.Google Scholar
Challis, JR, and Patrick, JE. Changes in the diurnal rhythms of plasma cortisol in women during the third trimester of pregnancy. Gynecol Obstet Invest. 1983, 16(1):27–32.Google Scholar
Landau, E, and Amar, L. Primary aldosteronism and pregnancy. Ann Endocrinol. 2016, 77(2):148–160.Google Scholar
Lumbers, ER, and Pringle, KG. Roles of the circulating renin-angiotensin-aldosterone system in human pregnancy. Am J Physiol Regul Integr Comp Physiol. 2014, 306(2):R91–101.Google Scholar
Levanovich, PE, Diaczok, A, and Rossi, NF. Clinical and molecular perspectives of monogenic hypertension. Curr Hypertens Rev. 2020, 16(2):91–107.Google Scholar
Ehrhart-Bornstein, M, Vukicevic, V, Chung, KF, et al. Chromaffin progenitor cells from the adrenal medulla. Cell Mol Neurobiol. 2010, 30(8):1417–1423.Google Scholar
van Berkel, A, Lenders, JW, and Timmers, HJ. Diagnosis of endocrine disease: Biochemical diagnosis of phaeochromocytoma and paraganglioma. Eur J Endocrinol. 2014, 170(3):R109–119.Google Scholar
Lenders, JWM, Langton, K, Langenhuijsen, JF, et al. Pheochromocytoma and pregnancy. Endocrinol Metab Clin North Am. 2019, 48(3):605–617.Google Scholar
Jaffe, RB, Mesiano, S, Smith, R, et al. The regulation and role of fetal adrenal development in human pregnancy. Endocr Res. 1998, 24(3–4):919–926.Google Scholar
Else, T, and Hammer, GD. Genetic analysis of adrenal absence: Agenesis and aplasia. Trends Endocrinol Metab. 2005, 16(10):458–468.Google Scholar
Schneiderman, M, Czuzoj-Shulman, N, Spence, AR, et al. Maternal and neonatal outcomes of pregnancies in women with Addison’s disease: A population-based cohort study on 7.7 million births. BJOG. 2017, 124(11):1772–1779.Google Scholar
Bothou, C, Anand, G, Li, D, et al. Current management and outcome of pregnancies in women with adrenal insufficiency: Experience from a multicenter survey. J Clin Endocrinol Metab. 2020, 105(8):e2853–2863.Google Scholar
Suri, D, Moran, J, Hibbard, JU, et al. Assessment of adrenal reserve in pregnancy: Defining the normal response to the adrenocorticotropin stimulation test. J Clin Endocrinol Metab. 2006, 91(10):3866–3872.Google Scholar
Lebbe, M, and Arlt, W. What is the best diagnostic and therapeutic management strategy for an Addison patient during pregnancy? Clin Endocrinol (Oxf). 2013, 78(4):497–502.Google Scholar
Bornstein, SR, Allolio, B, Arlt, W, et al. Diagnosis and treatment of primary adrenal insufficiency: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016, 101(2):364–389.Google Scholar
Anand, G, and Beuschlein, F. MANAGEMENT OF ENDOCRINE DISEASE: Fertility, pregnancy and lactation in women with adrenal insufficiency. Eur J Endocrinol. 2018, 178(2):R45–R53.Google Scholar
Murphy, VE, Fittock, RJ, Zarzycki, PK, et al. Metabolism of synthetic steroids by the human placenta. Placenta. 2007, 28(1):39–46.Google Scholar
Prete, A, Taylor, AE, Bancos, I, et al. Prevention of adrenal crisis: Cortisol responses to major stress compared to stress dose hydrocortisone delivery. J Clin Endocrinol Metab. 2020, 105(7):2262–2274.Google Scholar
Sacre, K, Dehoux, M, Chauveheid, MP, et al. Pituitary-adrenal function after prolonged glucocorticoid therapy for systemic inflammatory disorders: An observational study. J Clin Endocrinol Metab. 2013, 98(8):3199–3205.Google Scholar
Merke, DP, and Auchus, RJ. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med. 2020, 383(13):1248–1261.Google Scholar
Speiser, PW, Arlt, W, Auchus, RJ, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: An endocrine society* clinical practice guideline. J Clin Endocrinol Metab. 2018, 103(11):4043–4088.Google Scholar
New, MI, Abraham, M, Gonzalez, B, et al. Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Proc Natl Acad Sci USA. 2013, 110(7):2611–2616.Google Scholar
Reisch, N. Pregnancy in congenital adrenal hyperplasia. Endocrinol Metab Clin North Am. 2019, 48(3):619–641.Google Scholar
Heather, NL, Seneviratne, SN, Webster, D, et al. Newborn screening for congenital adrenal hyperplasia in New Zealand, 1994–2013. J Clin Endocrinol Metab. 2015, 100(3):1002–1008.Google Scholar
Merke, DP, and Bornstein, SR. Congenital adrenal hyperplasia. Lancet. 2005, 365(9477):2125–2136.Google Scholar
Mulaikal, RM, Migeon, CJ, and Rock, JA. Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med. 1987, 316(4):178–182.Google Scholar
Lekarev, O, Lin-Su, K, and Vogiatzi, MG. Infertility and reproductive function in patients with congenital adrenal hyperplasia: Pathophysiology, advances in management, and recent outcomes. Endocrinol Metab Clin North Am. 2015, 44(4):705–722.Google Scholar
Słowikowska-Hilczer, J, Hirschberg, AL, Claahsen-van der Grinten, H, et al. Fertility outcome and information on fertility issues in individuals with different forms of disorders of sex development: Findings from the dsd-LIFE study. Fertil Steril. 2017, 108(5):822–831.Google Scholar
Casteràs, A, De Silva, P, Rumsby, G, et al. Reassessing fecundity in women with classical congenital adrenal hyperplasia (CAH): Normal pregnancy rate but reduced fertility rate. Clin Endocrinol (Oxf). 2009, 70(6):833–837.Google Scholar
Bidet, M, Bellanné-Chantelot, C, Galand-Portier, M-B, et al. Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2010, 95(3):1182–1190.Google Scholar
Erichsen, MM, Husebye, ES, Michelsen, TM, et al. Sexuality and fertility in women with Addison’s disease. J Clin Endocrinol Metab. 2010, 95(9):4354–4360.Google Scholar
Nordenström, A, Frisén, L, Falhammar, H, et al. Sexual function and surgical outcome in women with congenital adrenal hyperplasia due to CYP21A2 deficiency: Clinical perspective and the patients’ perception. J Clin Endocrinol Metab. 2010, 95(8):3633–3640.Google Scholar
Krysiak, R, and Okopien, B. The effect of metformin on androgen production in diabetic women with non-classic congenital adrenal hyperplasia. Exp Clin Endocrinol Diabetes. 2014, 122(10):568–571.Google Scholar
Vermeulen, C, Geeven, G, de Wit, E, et al. Sensitive monogenic noninvasive prenatal diagnosis by targeted haplotyping. Am J Hum Genet. 2017, 101(3):326–339.Google Scholar
Simpson, JL, and Bischoff, F. Novel non-invasive prenatal diagnosis as related to congenital adrenal hyperplasia. Adv Exp Med Biol. 2011, 707:37–38.Google Scholar
McCann-Crosby, B, Placencia, FX, Adeyemi-Fowode, O, et al. Challenges in prenatal treatment with dexamethasone. Pediatr Endocrinol Rev. 2018, 16(1):186–193.Google Scholar
Besser, AG, Blakemore, JK, Grifo, JA, et al. Transfer of embryos with positive results following preimplantation genetic testing for monogenic disorders (PGT-M): Experience of two high-volume fertility clinics. J Assist Reprod Genet. 2019, 36(9):1949–1955.Google Scholar
Wallensteen, L, Zimmermann, M, Thomsen Sandberg, M, et al. Sex-dimorphic effects of prenatal treatment with dexamethasone. J Clin Endocrinol Metab. 2016, 101(10):3838–3846.Google Scholar
Hirvikoski, T, Nordenström, A, Wedell, A, et al. Prenatal dexamethasone treatment of children at risk for congenital adrenal hyperplasia: The Swedish experience and standpoint. J Clin Endocrinol Metab. 2012, 97(6):1881–1883.Google Scholar
Reisch, N, Willige, M, Kohn, D, et al. Frequency and causes of adrenal crises over lifetime in patients with 21-hydroxylase deficiency. Eur J Endocrinol. 2012, 167(1):35–42.Google Scholar
Balsamo, A, Baronio, F, Ortolano, R, et al. Congenital adrenal hyperplasias presenting in the newborn and young infant. Front Pediatr. 2020, 8:593315.Google Scholar
Caimari, F, Valassi, E, Garbayo, P, et al. Cushing’s syndrome and pregnancy outcomes: A systematic review of published cases. Endocrine. 2017, 55(2):555–563.Google Scholar
Nieman, LK, Biller, BM, Findling, JW, et al. The diagnosis of Cushing’s syndrome: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008, 93(5):1526–1540.Google Scholar
Brue, T, Amodru, V, and Castinetti, F. MANAGEMENT OF ENDOCRINE DISEASE: Management of Cushing’s syndrome during pregnancy: Solved and unsolved questions. Eur J Endocrinol. 2018, 178(6):R259–R266.Google Scholar
Lopes, LM, Francisco, RP, Galletta, MA, et al. Determination of nighttime salivary cortisol during pregnancy: Comparison with values in non-pregnancy and Cushing’s disease. Pituitary. 2016, 19(1):30–38.Google Scholar
Lindsay, JR, and Nieman, LK. Adrenal disorders in pregnancy. Endocrinol Metab Clin North Am. 2006, 35(1):1–20, v.Google Scholar
Achong, N, D’Emden, M, Fagermo, N, et al. Pregnancy-induced Cushing’s syndrome in recurrent pregnancies: Case report and literature review. Aust N Z J Obstet Gynaecol. 2012, 52(1):96–100.Google Scholar
Machado, MC, Fragoso, M, and Bronstein, MD. Pregnancy in patients with Cushing’s syndrome. Endocrinol Metab Clin North Am. 2018, 47(2):441–449.Google Scholar
Jolly, K, Darr, A, Arlt, W, et al. Surgery for Cushing’s disease in pregnancy: Our experience and a literature review. Ann R Coll Surg Engl. 2019, 101(1):e26–e31.Google Scholar
Close, CF, Mann, MC, Watts, JF, et al. ACTH-independent Cushing’s syndrome in pregnancy with spontaneous resolution after delivery: Control of the hypercortisolism with metyrapone. Clin Endocrinol (Oxf). 1993, 39(3):375–379.Google Scholar
Connell, JM, Cordiner, J, Davies, DL, et al. Pregnancy complicated by Cushing’s syndrome: Potential hazard of metyrapone therapy. Case report. Br J Obstet Gynaecol. 1985, 92(11):1192–1195.Google Scholar
Zieleniewski, W, and Michalak, R. A successful case of pregnancy in a woman with ACTH-independent Cushing’s syndrome treated with ketoconazole and metyrapone. Gynecol Endocrinol. 2017, 33(5):349–352.Google Scholar
Berwaerts, J, Verhelst, J, Mahler, C, et al. Cushing’s syndrome in pregnancy treated by ketoconazole: Case report and review of the literature. Gynecol Endocrinol. 1999, 13(3):175–182.Google Scholar
Yang, Y, Reincke, M, and Williams, TA. Prevalence, diagnosis and outcomes of treatment for primary aldosteronism. Best Pract Res Clin Endocrinol Metab. 2020, 34(2):101365.Google Scholar
Mulatero, P, Stowasser, M, Loh, KC, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab. 2004, 89(3):1045–1050.Google Scholar
Prada, ETA, Burrello, J, Reincke, M, et al. Old and new concepts in the molecular pathogenesis of primary aldosteronism. Hypertension. 2017, 70(5):875–881.Google Scholar
Sanga, V, Lenzini, L, Seccia, TM, et al. Familial hyperaldosteronism type 1 and pregnancy: Successful treatment with low dose dexamethasone. Blood Press. 2021, 1–5.Google Scholar
Morton, A. Primary aldosteronism and pregnancy. Pregnancy Hypertens. 2015, 5(4):259–262.Google Scholar
Malha, L, and August, P. Secondary hypertension in pregnancy. Curr Hypertens Rep. 2015, 17(7):53.Google Scholar
Zelinka, T, Petrák, O, Rosa, J, et al. Primary aldosteronism and pregnancy. Kidney Blood Press Res. 2020, 45(2):275–285.Google Scholar
Corsello, SM, and Paragliola, RM. Evaluation and management of endocrine hypertension during pregnancy. Endocrinol Metab Clin North Am. 2019, 48(4):829–842.Google Scholar
Hecker, A, Hasan, SH, and Neumann, F. Disturbances in sexual differentiation of rat foetuses following spironolactone treatment. Acta Endocrinol (Copenh). 1980, 95(4):540–545.Google Scholar
Riester, A, and Reincke, M. Progress in primary aldosteronism: Mineralocorticoid receptor antagonists and management of primary aldosteronism in pregnancy. Eur J Endocrinol. 2015, 172(1):R23–30.Google Scholar
Harrington, JL, Farley, DR, van Heerden, JA, et al. Adrenal tumors and pregnancy. World J Surg. 1999, 23(2):182–186.Google Scholar
Wing, LA, Conaglen, JV, Meyer-Rochow, GY, et al. Paraganglioma in pregnancy: A case series and review of the literature. J Clin Endocrinol Metab. 2015, 100(8):3202–3209.Google Scholar
Bancos, I, Atkinson, E, Eng, C, et al. Maternal and fetal outcomes in phaeochromocytoma and pregnancy: A multicentre retrospective cohort study and systematic review of literature. Lancet Diabetes Endocrinol. 2021, 9(1):13–21.Google Scholar
Manoharan, M, Sinha, P, and Sibtain, S. Adrenal disorders in pregnancy, labour and postpartum – An overview. J Obstet Gynaecol. 2020, 40(6):749–758.Google Scholar
Affinati, AH, and Auchus, RJ. Endocrine causes of hypertension in pregnancy. Gland Surg. 2020, 9(1):69–79.Google Scholar
Lenders, JW, Duh, QY, Eisenhofer, G, et al. Pheochromocytoma and paraganglioma: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014, 99(6):1915–1942.Google Scholar
Guidelines for Diagnostic Imaging During Pregnancy and Lactation. Committee Opinion No. 723. Obstet Gynecol. 2017, 130(2):e210–216.Google Scholar
Crona, J, Taïeb, D, and Pacak, K. New perspectives on pheochromocytoma and paraganglioma: Toward a molecular classification. Endocr Rev. 2017, 38(6):489–515.Google Scholar
Gaujoux, S, Hain, É, Marcellin, L, et al. Adrenalectomy during pregnancy: A 15-year experience at a tertiary referral center. Surgery. 2020, 168(2):335–339.Google Scholar
Oliva, R, Angelos, P, Kaplan, E, et al. Pheochromocytoma in pregnancy: A case series and review. Hypertension. 2010, 55(3):600–606.Google Scholar
Fassnacht, M, Kroiss, M, and Allolio, B. Update in adrenocortical carcinoma. J Clin Endocrinol Metab. 2013, 98(12):4551–4564.Google Scholar
Abiven-Lepage, G, Coste, J, Tissier, F, et al. Adrenocortical carcinoma and pregnancy: Clinical and biological features and prognosis. Eur J Endocrinol. 2010, 163(5):793–800.Google Scholar
Raffin-Sanson, ML, Abiven, G, Ritzel, K, et al. Adrenocortical carcinoma and pregnancy. Ann Endocrinol. 2016, 77(2):139–147.Google Scholar
Zhang, Y, Yuan, Z, Qiu, C, et al. The diagnosis and treatment of adrenocortical carcinoma in pregnancy: A case report. BMC Pregnancy Childbirth. 2020, 20(1):50.Google Scholar
de Corbière, P, Ritzel, K, Cazabat, L, et al. Pregnancy in women previously treated for an adrenocortical carcinoma. J Clin Endocrinol Metab. 2015, 100(12):4604–4611.Google Scholar
References
Houghton, LC, Lauria, M, Maas, P, et al. Circulating maternal and umbilical cord steroid hormone and insulin-like growth factor concentrations in twin and singleton pregnancies. J Dev Orig Health Dis. 2019, 10(2):232–236.Google Scholar
Kuijper, EA, Twisk, JW, Korsen, T, et al. Mid-pregnancy, perinatal, and neonatal reproductive endocrinology: A prospective cohort study in twins and singleton control subjects. Fertil Steril. 2015, 104(6):1527–15234.e1–9.Google Scholar
Póvoa, A, Xavier, P, Matias, A, et al. First trimester β-hCG and estradiol levels in singleton and twin pregnancies after assisted reproduction. J Perinat Med. 2018, 46(8):853–856.Google Scholar
Smith, R, Smith, JI, Shen, X, et al. Patterns of plasma corticotropin-releasing hormone, progesterone, estradiol, and estriol change and the onset of human labor. J Clin Endocrinol Metab. 2009, 94(6):2066–2074.Google Scholar
Thomas, HV, Murphy, MF, Key, TJ, et al. Pregnancy and menstrual hormone levels in mothers of twins compared to mothers of singletons. Ann Hum Biol. 1998, 25(1):69–75.Google Scholar
Fridström, M, Garoff, L, Sjöblom, P, et al. Human chorionic gonadotropin patterns in early pregnancy after assisted reproduction. Acta Obstet Gynecol Scand. 1995, 74(7):534–538.Google Scholar
Norman, RJ, McLoughlin, JW, Borthwick, GM, et al. Inhibin and relaxin concentrations in early singleton, multiple, and failing pregnancy: Relationship to gonadotropin and steroid profiles. Fertil Steril. 1993, 59(1):130–137.Google Scholar
Seravalli, V, Di Tommaso, M, Challis, JR, et al. Endocrinology of maternal-placental axis. In: Petraglia, F C, (Eds.). Female Reproductive Dysfunction. 2020; 397–410. Springer, Cham.Google Scholar
Lambers, MJ, Mager, E, Goutbeek, J, et al. Factors determining early pregnancy loss in singleton and multiple implantations. Hum Reprod. 2007, 22(1):275–279.Google Scholar
Matias, A, La Sala, GB, and Blickstein, I. Early loss rates of entire pregnancies after assisted reproduction are lower in twin than in singleton pregnancies. Fertil Steril. 2007, 88(5):1452–1454.Google Scholar
Gonzalez, MC, Reyes, H, Arrese, M, et al. Intrahepatic cholestasis of pregnancy in twin pregnancies. J Hepatol. 1989, 9(1):84–90.Google Scholar
Gardiner, FW, McCuaig, R, Arthur, C, et al. The prevalence and pregnancy outcomes of intrahepatic cholestasis of pregnancy: A retrospective clinical audit review. Obstet Med. 2019, 12(3):123–128.Google Scholar
Arrese, M, and Reyes, H. Intrahepatic cholestasis of pregnancy: A past and present riddle. Ann Hepatol. 2006, 5(3):202–205.Google Scholar
Lammert, F, Marschall, HU, Glantz, A, et al. Intrahepatic cholestasis of pregnancy: Molecular pathogenesis, diagnosis and management. J Hepatol. 2000, 33(6):1012–1021.Google Scholar
Reyes, H, and Simon, FR. Intrahepatic cholestasis of pregnancy: An estrogen-related disease. Semin Liver Dis. 1993, 13(3):289–301.Google Scholar
Wagner, M, and Trauner, M. Transcriptional regulation of hepatobiliary transport systems in health and disease: Implications for a rationale approach to the treatment of intrahepatic cholestasis. Ann Hepatol. 2005, 4(2):77–99.Google Scholar
Alkaabi, J, Almazrouei, R, Zoubeidi, T, et al. Burden, associated risk factors and adverse outcomes of gestational diabetes mellitus in twin pregnancies in Al Ain, UAE. BMC Pregnancy Childbirth. 2020, 20(1):612.Google Scholar
Schwartz, DB, Daoud, Y, Zazula, P, et al. Gestational diabetes mellitus: Metabolic and blood glucose parameters in singleton versus twin pregnancies. Am J Obstet Gynecol. 1999, 181(4):912–914.Google Scholar
Warren, WB, Goland, RS, Wardlaw, SL, et al. Elevated maternal plasma corticotropin releasing hormone levels in twin gestation. J Perinat Med. 1990, 18(1):39–44.Google Scholar
Spellacy, WN, Buhi, WC, and Birk, SA. Human placental lactogen levels in multiple pregnancies. Obstet Gynecol. 1978, 52(2):210–212.Google Scholar
Roach, VJ, Lau, TK, Wilson, D, et al. The incidence of gestational diabetes in multiple pregnancy. Aust N Z J Obstet Gynaecol. 1998, 38(1):56–57.Google Scholar
Swerdlow, AJ, De Stavola, BL, Swanwick, MA, et al. Risks of breast and testicular cancers in young adult twins in England and Wales: Evidence on prenatal and genetic aetiology. Lancet. 1997, 350(9093):1723–1728.Google Scholar
Trichopoulos, D. Hypothesis: Does breast cancer originate in utero? Lancet. 1990, 335(8695):939–940.Google Scholar
Tapp, AL, Maybery, MT, and Whitehouse, AJ. Evaluating the twin testosterone transfer hypothesis: A review of the empirical evidence. Horm Behav. 2011, 60(5):713–722.Google Scholar
Galiano, V, Solazzo, G, Rabinovici, J, et al. Cord blood androgen levels of females from same sex and opposite sex twins – A pilot study. Clin Endocrinol (Oxf). 2021, 94(1):85–89.Google Scholar
Hollier, LP, Keelan, JA, Hickey, M, et al. Measurement of androgen and estrogen concentrations in cord blood: accuracy, biological interpretation, and applications to understanding human behavioral development. Front Endocrinol (Lausanne). 2014, 5:64.Google Scholar
TambyRaja, RL, and Ratnam, SS. Plasma steroid changes in twin pregnancies. Prog Clin Biol Res. 1981;69a:189–195.Google Scholar
Stock, S, and Norman, J. Preterm and term labour in multiple pregnancies. Semin Fetal Neonatal Med. 2010, 15(6):336–341.Google Scholar
Heine, RP, McGregor, JA, Goodwin, TM, et al. Serial salivary estriol to detect an increased risk of preterm birth. Obstet Gynecol. 2000, 96(4):490–497.Google Scholar
Lachelin, GC, McGarrigle, HH, Seed, PT, et al. Low saliva progesterone concentrations are associated with spontaneous early preterm labour (before 34 weeks of gestation) in women at increased risk of preterm delivery. BJOG. 2009, 116(11):1515–1519.Google Scholar
Lim, H, Powell, S, McNamara, HC, et al. Placental hormone profiles as predictors of preterm birth in twin pregnancy: A prospective cohort study. PLoS ONE. 2017, 12(3):e0173732.Google Scholar
Johnsson, VL, Pedersen, NG, Worda, K, et al. Plasma progesterone, estradiol, and unconjugated estriol concentrations in twin pregnancies: Relation with cervical length and preterm delivery. Acta Obstet Gynecol Scand. 2019, 98(1):86–94.Google Scholar
da Fonseca, EB, Bittar, RE, Carvalho, MH, et al. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: A randomized placebo-controlled double-blind study. Am J Obstet Gynecol. 2003, 188(2):419–424.Google Scholar
Hassan, SS, Romero, R, Vidyadhari, D, et al. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: A multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2011, 38(1):18–31.Google Scholar
Norman, JE, Mackenzie, F, Owen, P, et al. Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): A randomised, double-blind, placebo-controlled study and meta-analysis. Lancet. 2009, 373(9680):2034–2040.Google Scholar
Rouse, DJ, Caritis, SN, Peaceman, AM, et al. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med. 2007, 357(5):454–461.Google Scholar
Lyall, F, Lye, S, Teoh, T, et al. Expression of Gsalpha, connexin-43, connexin-26, and EP1, 3, and 4 receptors in myometrium of prelabor singleton versus multiple gestations and the effects of mechanical stretch and steroids on Gsalpha. J Soc Gynecol Investig. 2002, 9(5):299–307.Google Scholar
Turton, P, Neilson, JP, Quenby, S, et al. A short review of twin pregnancy and how oxytocin receptor expression may differ in multiple pregnancy. Eur J Obstet Gynecol Reprod Biol. 2009, 144 Suppl 1:S40–44.Google Scholar
Turton, P, Arrowsmith, S, Prescott, J, et al. A comparison of the contractile properties of myometrium from singleton and twin pregnancies. PLoS ONE. 2013, 8(5):e63800.Google Scholar
Wray, S. Insights from physiology into myometrial function and dysfunction. Exp Physiol. 2015, 100(12):1468–1476.Google Scholar
References
Barker, DJP, Winter, PD, Osmond, C, et al. Weight in infancy and death from ischaemic heart disease. Lancet. 1989, 8663:577–580.Google Scholar
Barker, DJP, Bull, AR, Osmond, C, et al. Fetal and placental size and the risk of hypertension in adult life. Br Med J. 1990, 301:259–262.Google Scholar
Rich-Edwards, JW, Stampfer, MJ, Manson, JE, et al. Birthweight and risk of cardiovascular disease in a cohort of women followed up since 1976. Br Med J. 1997, 315:396–400.Google Scholar
Langley-Evans, SC, Gardner, D, and Jackson, AA. Maternal protein restriction influences the programming of the rat hypothalamic-pituitary adrenal axis. J Nutrition. 1996, 126:1578–1585.Google Scholar
Lillycrop, KA, Phillips, ES, Jackson, AA, et al. Dietary protein restriction of pregnant rats induces, and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. J. Nutrition. 2005, 135:1382–1386.Google Scholar
Meaney, MJ, S Zyf, M, and Seckl, JR. Epigenetic mechanisms of perinatal programming of hypothalamic-pituitary adrenal function and health. Trends Mol Med. 2007, 2007:269–277.Google Scholar
Langley-Evans, SC. Hypertension induced by foetal exposure to a maternal low-protein diet, in the rat, is prevented by pharmacological blockade of maternal glucocorticoid synthesis. J. Hypertension. 1997, 15:537–544.Google Scholar
Reynolds, RM, Labad, J, Buss, C, et al. Transmitting biological effects of stress in utero: Implications for mother and offspring. Psychoneuroendocrinology. 2013, 38:1843–1849.Google Scholar
Meaney, MJ. Maternal care, gene expression and the transmission of individual differences in stress reactivity across generations. Ann Rev Neurosci. 2001, 24:1161–1192.Google Scholar
Roseboom, TJ, van der Meulen, JH, Osmond, C, et al. Coronary heart disease after prenatal exposure to the Dutch famine, 1944–45. Heart. 2000, 84:595–598.Google Scholar
Eriksson, JG. Early growth, and coronary heart disease and type 2 diabetes: Experiences from the Helsinki birth cohort. Int J Obesity. 2006, 30:S18–S22.Google Scholar
Ozanne, SE, and Hales, NC. Peer fetal growth followed by rapid catch-up growth leads to premature death. Mech Ageing Dev. 2005, 126:852–854.Google Scholar
Gluckman, PD, Hanson, MA, Beedle, AS, et al. Predictive adaptive responses in perspective. Trends Endocrinol Metab. 2008, 19:109–110.Google Scholar
Gluckman, PD, Hanson, MA, and Low, FM. Evolutionary and developmental mismatches are consequences of adaptive developmental plasticity in humans and have implications for later disease risk. Phil Trans Royal Society B. 2019. https://doi.org/10.1098/rstb.2018.0109.Google Scholar
Braun, T, Challis, JR, Newnham, JP, et al. Early life glucocorticoid exposure: The hypothalamic-pituitary-adrenal axis, placental function and long-term disease risk. Endocr Rev. 2013, 34:885–916.Google Scholar
Seckl, JR, Benediktssion, R, Linsay, RS, et al. Placental 11b-hydroxysteroid dehydrogenase and the programming of hypertension. J Steroid Biochem Mol Biol. 1995, 55:447–450.Google Scholar
Connor, KL, Kibschull, M, Matysiak-Zablocki, E, et al. Maternal malnutrition impacts placental morphology and transporter expression: An origin for poor offspring growth. J Nutr Biochem. 2020, 78:108329.Google Scholar
Regnault, TR, Friedman, JE, Wilkening, RB, et al. Fetoplacental transport and utilization of amino acids in IUGR – A review. Placenta. 2005. Suppl A; S52–S62.Google Scholar
Audette, MC, Challis, JRG, Jones, RL, et al. Antenatal dexamethasone treatment in mid-gestation reduces system A transporter activity in the late gestation murine placenta. Endocrinology. 2011. 152: 3561–3570.Google Scholar
Challis, JRG, Matthews, SG, Gibb, W, et al. Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev. 2000. 21:514–550.Google Scholar
Challis, JRG, and Brooks, AN. Maturation and activation of hypothalamic-pituitary-adrenal function in fetal sheep. Endocr Rev. 1989, 10:182–204.Google Scholar
Braun, T, Li, S, Sloboda, DM, et al. Effects of maternal dexamethasone treatment in early pregnancy on pituitary-adrenal axis in fetal sheep. Endocrinology. 2009 150:5466–5477.Google Scholar
Painter, RC, Roseboom, TJ, and de Rooij, SR. Long-term effects of prenatal stress and glucocorticoid exposure. Birth Defects Res Embryo Today. 2021, 96:315–324.Google Scholar
Reynolds, RM. Glucocorticoid excess and the developmental origins of disease; two decades of testing the hypothesis. Psychoneuroendocrinology. 2013, 38:1–11.Google Scholar
Waterland, RA, and Jirtle, RL. Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition. 2004, 20:63–68.Google Scholar
Bloomfield, F, Oliver, M, Hawkins, P, et al. A periconceptional nutritional origin for non-infectious preterm birth. Science. 2003, 300:606.Google Scholar
Bloomfield, FH, Oliver, MH, Hawkins, P, et al. Periconceptional undernutrition in sheep accelerates maturation of the fetal hypothalamic-pituitary-adrenal axis in late gestation. Endocrinology. 2004, 145:4278–4285.Google Scholar
Connor, KL, Challis, JRG, vanZijl, P, et al. Do alterations in placental 11beta-hydroxysteroid dehydrogenase (11betaHSD) activities explain differences in fetal hypothalamic-pituitary-adrenal (HPA) function following periconceptional undernutrition or twinning in sheep. Reprod Sci. 2009 16:1201–1212.Google Scholar
Begum, G, Stevens, A, Connor, K, et al. Epigenetic changes in fetal hypothalamic energy regulating pathways are associated with maternal undernutrition and twinning. FASEB J. 2012, 26:1694–1703.Google Scholar
Begum, G, Davies, A, Stevens, A, et al. Maternal undernutrition programs tissue-specific epigenetic changes in the glucocorticoid receptor in adult offspring. Endocrinology. 2013, 154:4560–4569.Google Scholar
Johnstone, JF, Godfrey, KM, Zelsman, M, et al. The relationship between placental 11β HSD-2 and maternal body composition, age and dieting status. 2005 Society for Gynecologic Investigation Annual Meeting, Los Angeles, 2005.Google Scholar
Braun, T, Li, S, Sloboda, DM, et al. Effects of maternal dexamethasone treatment in early pregnancy on pituitary-adrenal axis in fetal sheep. Endocrinology. 2009, 150: 5466–5477Google Scholar
Constantinof, A, Moisiadis, VG, and Matthews, SG. Programming of stress pathways: A transgenerational perspective. J Steroid Biochem Mol Biol. 2016, 160; 175–180.Google Scholar
Petraglia, F, Imperatore, A, and Challis, JRG, Neuroendocrine mechanisms in pregnancy and parturition. Endocr Rev. 2010, 31:783–816.Google Scholar
Sun, K, Yang, K, and Challis, JRG. Differential expression of 11betahydroxysteroid dehydrogenase types 1 and 2 in human placenta and foetal membranes. J. Clin Endocr Metab. 1997, 82:300–305.Google Scholar
Alexander, N, Rosenlocher, F, and Stadler, T. Impact of antenatal synthetic glucocorticoid exposure on endocrine stress reactivity in term-born children. J Clin Endocr Metab. 2012, 97:3538–3544.Google Scholar
Asztalos, EV, Murphy, KE, and Matthews, SG. A growing dilemma: Antenatal corticosteroids and long-term consequences. Am J Perinatol. 2020, https://doi.org/10.1055/s-0040-1718573.Google Scholar
Roseboom, TJ, Ozanne, SE, Godfrey, KM, et al. Unheard, unseen and unprotected: DOHaD Council’s call for action to protect the younger generation from the long-term effects of COVID-19. J. Develop Orig Health Dis. 2021, https://doi.org/10.1017/S2040174420000847.Google Scholar
Shenk, CE, O’Donnell, KJ, Pokhvisneva, I, et al. Epigenetic age acceleration and risk for posttraumatic stress disorder following exposure to substantiated child maltreatment. J Clin Child Adolesc Psychol. 2021, 1–11.Google Scholar
Franke, HA. Toxic stress: Effects, prevention and treatment. Children. 2014, 1:390–402.Google Scholar
Anda, RF, Felitti, VJ, Bremner, JD, et al. The enduring effects of abuse and related adverse experiences in childhood: A convergence of evidence from neurobiology and epidemiology. Eur Arch Psychiat Clin Neurosci. 2006, 256:174–186.Google Scholar
Kuffer, AL, Thoma, MV, and Maercker, A. Transgenerational aspects of former Swiss child laborers: Do second generations suffer from their parents’ adverse early-life experiences. Eur J. Psychotraumatol. 2016, 7: https://doi.org/10.3402/ejptv7.30804.Google Scholar
Strobel, NA, Richardson, A, Shepherd, CCJ, et al. Modelling factors for Aboriginal and Torres Strait Islander child neurodevelopment outcomes: A latent class analysis. Paediatr Perinat Epidemiol. 2019, 00:1–12. https://doi.org/10.1111/ppe.12616.Google Scholar
Boyce, WT, and Kobor, MS. Development and the epigenome: The ‘synapse’ of gene – Environment interplay. Develop Sci. 2015, 18:1–23.Google Scholar
Chen, L, Pan, H, Tuan, TA, et al. GUSTO Study Group. Brain-derived Neurotrophic Factor (BDNF) val66met polymorphism influences the association of the methylome with maternal anxiety and neonatal brain volumes. Develop Psychopathol. 2015, 271:137–150.Google Scholar
Meaney, MJ. Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Ann Rev Neurosci. 2001, 24:1161–1192.Google Scholar
Moisiadis, VG, and Matthews, SG. Glucocorticoids and fetal programming part1: Outcomes. Nat Rev Endocrinol. 2014, 10:391–402.Google Scholar
Moisiadis, VG, and Matthews, SG. Glucocorticoids and fetal programming part 2: Mechanisms. Nat Rev Endocrinol. 2014, 10:403–411.Google Scholar
Ibanez, L, Potau, N, Ferrer, A, et al. Reduced ovulation rate in adolescent girls born small for gestational age. J Clin Endocrinol Metab. 2002, 87:3391–3393.Google Scholar
Sloboda, DM, Hickey, M, and Hart, R. Reproduction in females: The role of early life environment. Hum Reprod Update. 2011, 17:210–227.Google Scholar
Sloboda, DM, Hart, R, Doherty, DA, et al. Age at menarche: Influences of prenatal and postnatal growth. J Clin Endocrinol Metab. 2007, 92:46–50.Google Scholar
. Sloboda, DM, Howie, GJ, Gluckman, PD, et al. Pre-and postnatal nutritional histories influence reproductive maturation and ovarian function in the rat. PLoS ONE. 2009, 4:e6744.Google Scholar
Jazwiec, P, and Sloboda, DM. Nutritional adversity, sex and reproduction: Thirty years on from Barker and what have we learned? J Endocrinol. 2019, 242:T51–T68.Google Scholar
Tsoulis, M, Chang, P Moore, CJ, et al. Maternal high fat diet induced loss of fetal oocytes is associated with compromised follicle growth in adult offspring. Biol Reprod. 2016, 94:94.Google Scholar
Vannuccini, S, Lazzeri, L, Orlandini, C, et al. Potential influence of in utero and early neonatal exposures on the later development of endometriosis. Fertil Steril. 2016 105:997–1002.Google Scholar
Liu, S, Cui, H, Zhang, Q, et al. Influence of early-life factors on the development of endometriosis. Eur J Contracept Reprod Health Care. 2019, 24:216–221.Google Scholar
Borghese, B, Sibiude, J, Santulli, P, et al. Low birth weight is strongly associated with the risk of deep infiltrating endometriosis: Results of a 743 case-control study. PLoS ONE. 2015, 10:e0117387.Google Scholar
Dumesic, DA, Goodarzi, MO, Chazenbalk, GD, et al. Intrauterine environment and polycystic ovary syndrome. Semin Reprod Med. 2014, 32:159–165.Google Scholar
Flint, HJ, Scott, KP, Louis, P, et al. The role of gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol. 2012, 9:577–589.Google Scholar
Gohir, W, Ratcliffe, EM, and Sloboda, DM. Of the bugs that shape us: Maternal obesity, the gut microbiome and longterm disease risk. Pediatr Res. 2014, 77:196–204.Google Scholar
Gohir, W, Whelan, FJ, Surette, MG, et al. 2015. Pregnancy-related changes in the maternal gut microbiota are dependent upon the mother’s periconceptional diet. Gut Microbiobes. 6:310–320.Google Scholar
Finlay, BB, Amato, KR, Azad, M, et al. The hygiene hypothesis, the COVID pandemic, and consequences for the human microbiome. Proc Natl Acad Sci. 2021, 118:e2010217118.Google Scholar
Abdul-Hussein, A, Kareem, A, Tewari, S, et al. Early life risk and resiliency factors and their influences on developmental outcomes and disease pathways: A rapid evidence review of systematic reviews and meta-analyses. J Develop Orig Health Dis. 2021 (in press).Google Scholar
Britto, PR, Lye, SJ, Proulx, K, et al. Nurturing care: Promoting early childhood development. Lancet. 2017, 389:91–102.Google Scholar
Daelmans, B, Darmstadt, GL, Lombardi, J, et al. Early childhood development, the foundation of sustainable development. Lancet. 2017, 389:9–11.Google Scholar